好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2011 Annual Meeting | Poster Session 02

Tuesday 04/12/11
07:30 AM - 12:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Neuro-oncology, Aging and Dementia, Anterior Horn, Child Neurology/Developmental Neurobiology, Critical Care/Emergency Neurology/Trauma, Epilepsy, Interventional Neurology, MS and Related Diseases, Muscle Disease/Neuromuscular Junction, Neurologic 好色先生, Neurotoxicology, Peripheral Nerve
No CME available
Event Timeline
07:30 AM - 12:00 PM Abstract 001 - Utilizing a National Continuing Medical 好色先生 (CME) Series to Highlight Emerging Therapeutic Opportunities in Spinal Muscular Atrophy (SMA)
07:30 AM - 12:00 PM Abstract 002 - Neurology Grand Rounds: Can They Still Be Grand in 2010?
07:30 AM - 12:00 PM Abstract 003 - Why We Are, Who We Are?
07:30 AM - 12:00 PM Abstract 004 - Measuring Blood Pressure in the Neurology Office Setting: A Missed Part of the Physical Examination
07:30 AM - 12:00 PM Abstract 005 - Neurodegenerative Disease Caregivers and Clinicians: Partnering for Brain Donation
07:30 AM - 12:00 PM Abstract 006 - Survey Shows Public Unawareness of the Role of Neurologists in Healthcare
07:30 AM - 12:00 PM Abstract 007 - Economic, Social and Psychological Barriers to Calling 911 for Acute Stroke: Conclusions from Focus Group Discussions with Survivors and Caregivers
07:30 AM - 12:00 PM Abstract 008 - Improving Detection and Treatment of Non-Motor Manifestations in Parkinson's Disease: A Patient 好色先生al Tool
07:30 AM - 12:00 PM Abstract 009 - Phase II Study of Monthly Pasireotide LAR (SOM230C) for Recurrent or Progressive Meningioma
07:30 AM - 12:00 PM Abstract 010 - Hydroxyurea for Recurrent Surgery and Radiation Refractory Meningioma
07:30 AM - 12:00 PM Abstract 011 - Atypical and Anaplastic Meningiomas Treated with Bevacizumab
07:30 AM - 12:00 PM Abstract 012 - Irinotecan/Bevacizumab for the Treatment of Refractory Brain Metastases in Patients with Her2-Neu Positive Breast Cancer
07:30 AM - 12:00 PM Abstract 013 - Bevacizumab Efficacy in Symptomatic Central Nervous System Radiation Necrosis Complicating Radiation for Extra-Cranial Cancers
07:30 AM - 12:00 PM Abstract 014 - Treatment of Primary CNS Lymphoma (PCNSL) in Elderly Patients with Pemetrexed, a Novel Anti-Folate
07:30 AM - 12:00 PM Abstract 015 - Autologous Stem Cell Transplant for Relapsed Primary Central Nervous System Lymphoma: A Case Series and Review of the Literature
07:30 AM - 12:00 PM Abstract 016 - Intramedullary Spinal Cord Lymphoma: Clinical Presentation, Neuroimaging, Diagnosis and Outcome
07:30 AM - 12:00 PM Abstract 017 - Durable Response, Time to Progression, and Survival in a Patient Treated for Leptomeningeal Metastasis of Systemic Lymphoma
07:30 AM - 12:00 PM Abstract 018 - Isolated Leptomeningeal Infiltration of B-Cell Lymphoma Diagnosed by Flow Cytometry
07:30 AM - 12:00 PM Abstract 019 - Prolonged Durable Progression-Free Survival in Newly Diagnosed Glioblastoma Following Dendritic Cell Immunotherapy (ICT-107)
07:30 AM - 12:00 PM Abstract 020 - Bevacizumab Chemotherapy for the Treatment of Newly Diagnosed and Progressive Primary Brain Tumors
07:30 AM - 12:00 PM Abstract 021 - Dose Dense One Week On/One Week Off Temozolomide in Recurrent Glioma
07:30 AM - 12:00 PM Abstract 022 - Lacosamide in the Management of Patients with Malignant Primary Brain Tumors
07:30 AM - 12:00 PM Abstract 023 - Temozolamide/Bevacizumab for the Treatment of a Patient with Progressive Myxopapillary Ependymoma
07:30 AM - 12:00 PM Abstract 025 - Glioblastoma Multiforme Presenting as Sigmoid Sinus Thrombosis
07:30 AM - 12:00 PM Abstract 026 - Status Epilepticus in Patients with Glioma: Association with Tumor Progression or Transformation
07:30 AM - 12:00 PM Abstract 027 - Bitemporal Glioblastoma Multiforme Presenting as Korsakoff's Syndrome: A Case Report
07:30 AM - 12:00 PM Abstract 028 - Plasmablastic Lymphoma after Standard Dose Temozolomide for Glioblastoma
07:30 AM - 12:00 PM Abstract 029 - Mortality and Discharge Home Following Closed Brain Biopsy in the State of California, 2003-2007
07:30 AM - 12:00 PM Abstract 030 - Reasons for Hospitalization in Patients with Malignant Brain Tumors
07:30 AM - 12:00 PM Abstract 031 - Single Institution Retrospective Analysis of Outcomes and Survivals in High Grade Gliomas Patients Treated with Concurrent Chemoradiation Followed by Adjuvant Temozolomide
07:30 AM - 12:00 PM Abstract 032 - Incidence of Central Nervous System Tumors in Two Different Populations from Argentina (Part 2): Clinical, Radiological and Histopathological Characteristics of Central Nervous System Metastasis
07:30 AM - 12:00 PM Abstract 033 - Retrospective Analysis of Central Nervous System Tumors in a Private Hospital from Monterrey, Mexico
07:30 AM - 12:00 PM Abstract 034 - Unusual Case of Conus Medullaris Tumor-Like Lesion in a Patient with Adult Alexander Disease
07:30 AM - 12:00 PM Abstract 035 - The Clinical Spectrum of Anti-GAD Antibody-Positive Patients
07:30 AM - 12:00 PM Abstract 036 - May ALS Be Considered a Paraneoplastic Disorder? Results from an Epidemiological-Based Series
07:30 AM - 12:00 PM Abstract 037 - Non-Hodgkin's Lymphoma of the Adrenal Glands with Associated CNS Lesions: A Case Report and Review of the Literature
07:30 AM - 12:00 PM Abstract 038 - Bing-Neel Syndrome: A Case Report
07:30 AM - 12:00 PM Abstract 039 - Severe Chronic Post-Transplant Headaches in Multivisceral and Small Bowel Transplant Recipients
07:30 AM - 12:00 PM Abstract 040 - The Spectrum of Neurologic Disorders Associated with TNF alpha Inhibitor Therapy: A Case Series
07:30 AM - 12:00 PM Abstract 041 - Characteristics of Persons with Overactive Bladder of Presumed Neurologic Origin: Results from the Boston Area Community Health (BACH) Survey
07:30 AM - 12:00 PM Abstract 042 - Muscle Cramps and Neuropathies in Patients with Allogeneic Hematopoietic Stem Cell Transplantation and Graft-Versus-Host Disease: A Retrospective Study
07:30 AM - 12:00 PM Abstract 043 - Paraneoplastic Anti-HU Syndrome Associated with Uterine Tumor
07:30 AM - 12:00 PM Abstract 044 - Spinal Neurosarcoidosis: A Case Series of 12 Patients
07:30 AM - 12:00 PM Abstract 045 - Infectious and Non-Infectious Intracranial Caseating Granulomas
07:30 AM - 12:00 PM Abstract 046 - Fulminant Chronic Inflammatory Demyelinating Polyneuropathy and Myositis: Initial Manifestations of Sjogren's Syndrome
07:30 AM - 12:00 PM Abstract 047 - Neurologic Adverse Events with the Use of Oseltamivir at Prophylactic vs Therapeutic Dose
07:30 AM - 12:00 PM Abstract 048 - Stroke and Cancer: Risk Factors, Physiopathologic Mechanisms, Clinical Presentation and Outcome
07:30 AM - 12:00 PM Abstract 050 - Anti IL-6 Antibody Suppresses the Inflammatory and Degenerative Change in the Muscle of SJL/J Mice
07:30 AM - 12:00 PM Abstract 051 - Mitochondrial Abnormalities in Dermatomyositis
07:30 AM - 12:00 PM Abstract 052 - Semi-Quantitative Measurement of Thigh Muscles Inflammation in Patients with Juvenile Dermatomyositis. Correlation with Rankin Scale, Creating Phosphokonase (CPK) and Lactate Dehydrogenase (LDH)
07:30 AM - 12:00 PM Abstract 053 - Pilot Trial of Lithium Treatment in Inclusion Body Myositis
07:30 AM - 12:00 PM Abstract 054 - Experimental Impairment of the Autophagosomal-Lysosomal Pathway (ALP) in Our Cultured Human-Muscle-Fibers Model of s-IBM (IBM-CHMFs Model) Activates [gamma]-Secretase, Resulting in Adversely Increased Production of Amyloid-[beta]42 (A[beta]42) and Its Subsequent Detrimental Oligomerization. Relevance to Sporadic Inclusion-Body Myositis (s-IBM) Pathogenesis
07:30 AM - 12:00 PM Abstract 055 - Immunosuppressive Treatments Do Not Alter Natural History of Sporadic Inclusion Body Myositis
07:30 AM - 12:00 PM Abstract 056 - Myopathies after Vaccination in the United States. A Report from the CDC/FDA Vaccine Adverse Event Reporting System. (1990-2010)
07:30 AM - 12:00 PM Abstract 057 - Muscle Sarcoidosis Diagnosed by Muscle Ultrasonography; 2 Case Reports
07:30 AM - 12:00 PM Abstract 058 - The Health-Related Needs of Patients and Families Affected by Duchenne and Becker Muscular Dystrophy (DBMD): Data from the Muscular Dystrophy Surveillance, Tracking and Research Network (MDSTARNet)
07:30 AM - 12:00 PM Abstract 059 - A Randomized, Placebo-Controlled, Multiple-Ascending Dose Study of ACE-031 (ActRIIB-IgG1) in Duchenne Muscular Dystrophy (DMD)
07:30 AM - 12:00 PM Abstract 060 - Health Care Services Received by Patients with Duchenne/Becker Muscular Dystrophy (DBMD): Data from the Muscular Dystrophy Surveillance, Tracking and Research Network (MDSTARNet)
07:30 AM - 12:00 PM Abstract 061 - Pre-Diagnostic Parent Experiences in Duchenne and Becker Muscular Dystrophies, Congenital Muscular Dystrophies, and Spinal Muscular Atrophies: A Survey of the National Task Force for the Early Identification of Childhood Neuromuscular Disorders
07:30 AM - 12:00 PM Abstract 062 - A Canadian Survey on Lung Volume Recruitment (LVR) in Children with Duchenne Muscular Dystrophy
07:30 AM - 12:00 PM Abstract 063 - Assessment of Muscle Strength in Healthy Children and Ambulant Boys with Duchenne Muscular Dystrophy at Ages 6 through 11 Years of Age
07:30 AM - 12:00 PM Abstract 064 - Impairment of Excitation-Contraction Coupling in Patients with Duchenne Musclar Dystrophy
07:30 AM - 12:00 PM Abstract 065 - Use of Optical Coherence Tomography for Idiopathic Intracranial Hypertension in Boys with Duchenne Muscular Dystrophy
07:30 AM - 12:00 PM Abstract 066 - Clinical and Preclinical Comparison of the Pharmacokinetic Parameters of AVI-4658, a Phosphorodiamidate Morpholino Oligomer for the Treatment of Duchenne Muscular Dystrophy
07:30 AM - 12:00 PM Abstract 067 - Novel Pointmutation in R1 Domain of Dystrophin Gene Causes Missfolding of Dystrophin and Becker's Muscular Dystrophy
07:30 AM - 12:00 PM Abstract 068 - Utility of Diagnostic Tests in Small Fiber Neuropathy: Proposal of New Diagnostic Criteria
07:30 AM - 12:00 PM Abstract 069 - Small Fiber Neuropathy: Clinical and Laboratory Correlations
07:30 AM - 12:00 PM Abstract 070 - Improvement in Small Fiber Neuropathies Following Immunomodulatory Therapy
07:30 AM - 12:00 PM Abstract 071 - Spinal Cord Stimulation Reduces Metabolic Activity in the Spinal Cord Superficial Dorsal Horn in Rats with Nerve Injury Induced Pain
07:30 AM - 12:00 PM Abstract 072 - Efficacy of NGX-4010, a Prescription Strength Capsaicin 8% Patch for the Treatment of Postherpetic Neuralgia, across a Range of Patient Populations
07:30 AM - 12:00 PM Abstract 073 - Duration of Treatment Response to NGX-4010, a Prescription Strength Capsaicin 8% Patch, in Patients with Postherptic Neuralgia
07:30 AM - 12:00 PM Abstract 074 - Efficacy and Safety of NGX-4010, a Prescription Strength Capsaicin 8% Patch, as Monotherapy for the Treatment of Postherpetic Neuralgia
07:30 AM - 12:00 PM Abstract 075 - A Comprehensive Evaluation of the Disease-Modifying Effects of Tafamidis in Patients with Transthyretin Type Familial Amyloid Polyneuropathy
07:30 AM - 12:00 PM Abstract 076 - Baseline Neurologic Function in Symptomatic Patients in the Transthyretin Amyloidosis Outcomes Survey (THAOS)
07:30 AM - 12:00 PM Abstract 078 - Clinical Features and Haplotype Analysis of Newly Identified Patients with Gelsolin-Related Familial Amyoidotic Polyneuropathy TypeIV in Japan
07:30 AM - 12:00 PM Abstract 079 - High Prevalence of Wild-Type TTR Deposition in Patients with Idiopathic Carpal Tunnel Syndrome: A Common Cause of Carpal Tunnel Syndrome in the Elderly
07:30 AM - 12:00 PM Abstract 080 - Is It Possible To Obtain Good Results after Surgical Release in Patients with Severe CTS?
07:30 AM - 12:00 PM Abstract 081 - Clinical and Electrophysiological Correlations Concerning Patients with Carpal Tunnel Syndrome
07:30 AM - 12:00 PM Abstract 082 - Severe Sciatic Nerve Injury, a Complication of Surgery for Piriformis Syndrome
07:30 AM - 12:00 PM Abstract 083 - Characteristics of Carpal Tunnel Syndrome (CTS) in Patients with AV Fistulas for Hemodialysis
07:30 AM - 12:00 PM Abstract 084 - Herpes Zoster Limb Paresis Frequently Localizes to the Plexus and Peripheral Nerve
07:30 AM - 12:00 PM Abstract 085 - Coffee and Amyotrophic Lateral Sclerosis: A Possible Preventive Role
07:30 AM - 12:00 PM Abstract 086 - Changing Mortality for Motor Neuron Disease in France (1968-2007): An Age-Period-Cohort Analysis
07:30 AM - 12:00 PM Abstract 087 - A Spatial Analysis of Amyotrophic Lateral Sclerosis in Northern New England
07:30 AM - 12:00 PM Abstract 088 - State and Metropolitan Area-Based Amyotrophic Lateral Sclerosis (ALS) Surveillance
07:30 AM - 12:00 PM Abstract 089 - Incidence of Amyotrophic Lateral Sclerosis in Argentina
07:30 AM - 12:00 PM Abstract 090 - Survival and Clinical Features in Mexican Amyotrophic Lateral Sclerosis Patients
07:30 AM - 12:00 PM Abstract 092 - Smoking, Alcohol Consumption and the Risk of Amyotrophic Lateral Sclerosis: A Population-Based Study
07:30 AM - 12:00 PM Abstract 093 - Population Based Epidemiology of ALS in the Netherlands Using Capture-Recapture Methodology
07:30 AM - 12:00 PM Abstract 094 - Optineurin Immuno-Reactive Inclusions Are a Common Feature in Sporadic and Non-SOD1 Familial Amyotrophic Lateral Sclerosis
07:30 AM - 12:00 PM Abstract 095 - Predisposing Factors for Anxiety in Elderly Patients with Epilepsy
07:30 AM - 12:00 PM Abstract 096 - Neuropsychiatric Profile of a Hispanic, Medically Underserved Population with Epilepsy
07:30 AM - 12:00 PM Abstract 097 - Epilepsy: A Medical Condition or a Taboo in India
07:30 AM - 12:00 PM Abstract 098 - The Efficacy of Formal Patient Epilepsy 好色先生al Programs: A Prospective Study with Pre and Post 好色先生al Module Questionnaires
07:30 AM - 12:00 PM Abstract 099 - Seizing the World Wide Web: Assessing Epilepsy Information on the Internet Using the Quantitative Characteristic Scale (QCS)
07:30 AM - 12:00 PM Abstract 100 - PatientsLikeMe[reg], a Data-Sharing Online Community: Benefits for Patients with Epilepsy
07:30 AM - 12:00 PM Abstract 101 - Correlation of Diagnostic Insight with Short-Term Outcome of Psychogenic Non-Epileptic Events
07:30 AM - 12:00 PM Abstract 102 - Utility of the "Stuffed Animal Sign" and Other Circumstantial and Behavioral Features in the Diagnosis of Epileptic and Non-Epileptic Seizures
07:30 AM - 12:00 PM Abstract 103 - Relationship of Age and Gender to Non-Epileptic Events in the Epilepsy Monitoring Unit
07:30 AM - 12:00 PM Abstract 104 - Depression Symptoms over Time in Epilepsy
07:30 AM - 12:00 PM Abstract 105 - Does Diabetes Mellitus Alter the Onset and Clinical Course of Vascular Dementia?
07:30 AM - 12:00 PM Abstract 106 - The Local Continuity of Rest-Activity Patterns Is Associated with Cognitive Function in Old Age
07:30 AM - 12:00 PM Abstract 107 - Atrial Fibrillation Increases the Risk of Non-Amnestic MCI
07:30 AM - 12:00 PM Abstract 108 - Cerebral Amyloid Angiopathy Is Associated with APOE4 and CERAD Plaque Staging, but Not Clinical Dementia in the Oldest-Old
07:30 AM - 12:00 PM Abstract 109 - Genetic Influences in the Progression of MCI to Different Negative Health Outcomes
07:30 AM - 12:00 PM Abstract 110 - Multilingualism Protects from Cognitive Impairment. A Field Study of Seniors Living in a Multilingual Environment
07:30 AM - 12:00 PM Abstract 111 - Lipid-Lowering Drugs Are Associated with Lower Decline of Walking Speed in the Elderly: The 3C Study
07:30 AM - 12:00 PM Abstract 112 - Severity of Cognitive Impairment in Patients with Moderate Chronic Kidney Disease Compared with Hemodialysis Patients and Controls
07:30 AM - 12:00 PM Abstract 113 - Probable REM Sleep Behavior Disorder Confers an Increased Risk of Cognitive Impairment and/or Parkinsonism in Cognitively Normal Subjects at Four-Year Follow-Up: The Mayo Clinic Study of Aging
07:30 AM - 12:00 PM Abstract 114 - Occurrence of Misidentification Symptoms in Alzheimer's Disease
07:30 AM - 12:00 PM Abstract 115 - Atherosclerotic Indices for the Prediction of Cognitive Impairment in a General Population: J-SHIPP Study
07:30 AM - 12:00 PM Abstract 116 - Risk Factors and Prevalence of Dementia and Alzheimer's Disease in Pichincha, Ecuador - FARYPDEA Study
07:30 AM - 12:00 PM Abstract 117 - Tumor Diagnosis Preceding Alzheimer's Disease: A Case-Control Study
07:30 AM - 12:00 PM Abstract 118 - Apolipoprotein E-[epsilon]4, Head Circumference and Diabetes, but Not Sex, Predict Duration of CDR 0.5: The Kame Project
07:30 AM - 12:00 PM Abstract 119 - Community Outreach Self-Administered Screening Uncovers Mild Cognitive Impairment and Dementia among Seniors
07:30 AM - 12:00 PM Abstract 120 - Poor Physical Performance Is Associated with Dementia in the Oldest Old
07:30 AM - 12:00 PM Abstract 121 - Prevalence of Inflammatory Conditions in Semantic Dementia
07:30 AM - 12:00 PM Abstract 123 - Diet Changes with Alzheimer's Disease Onset
07:30 AM - 12:00 PM Abstract 124 - Differences in the Association of Peripheral Insulin and Cognitive Function in Non-Diabetic AD Cases and Normal Controls
07:30 AM - 12:00 PM Abstract 125 - The California Parkinson's Disease Registry Pilot Project in Santa Clara County, CA
07:30 AM - 12:00 PM Abstract 127 - Caffeine in Parkinson's Disease: A Dose-Finding Study
07:30 AM - 12:00 PM Abstract 128 - Confirmation Study of Association of PARK16 and Parkinson's Disease in Han Chinese
07:30 AM - 12:00 PM Abstract 129 - Neuroleptics, Flunarizine, and the Risk of Parkinson's Disease in a 15 Years Prospective Population-Based Elderly Cohort
07:30 AM - 12:00 PM Abstract 130 - Are There Gender-Related Differences in the Progression of Parkinson's Disease? Findings from a Longitudinal [11C]([plusmn])Dihydrotetrabenazine PET Study
07:30 AM - 12:00 PM Abstract 131 - Clinical Features of Young-Onset Versus Late-Onset Parkinson's Disease
07:30 AM - 12:00 PM Abstract 132 - Demographics and Distribution of Parkinson's Disease/Parkinsonism by Military Period of Service among Veterans Seen within the Veterans Affairs Healthcare System, FY 2002-2008
07:30 AM - 12:00 PM Abstract 133 - Clioquinol and Parkinson Disease: Study from Patients with Subacute Myelo-Optico-Neuropathy (SMON) in Japan
07:30 AM - 12:00 PM Abstract 134 - The Motor Features of Drug-Induced Parkinsonism: Does Drug Class Matter?
07:30 AM - 12:00 PM Abstract 135 - Cervical Dystonia and Hand Tremor (CD+) - A Distinct Phenotype from Cervical Dystonia (CD) and Essential Tremor (ET)?
07:30 AM - 12:00 PM Abstract 136 - Estimating Annual Rate of Decline: Prospective, Longitudinal Data on Arm Tremor Severity in Two Groups of Essential Tremor Cases
07:30 AM - 12:00 PM Abstract 137 - Essential Tremor Prevalence Is Low in the Druze Population in Northern Israel
07:30 AM - 12:00 PM Abstract 138 - DAT-SPECT in Patients with Long-Standing Essential and Associated Rest Tremor
07:30 AM - 12:00 PM Abstract 139 - Essential Tremor Quantification during Activities of Daily Living
07:30 AM - 12:00 PM Abstract 140 - Autonomic Function Is Normal in Essential Tremor but Not Parkinson's Disease
07:30 AM - 12:00 PM Abstract 141 - Metabolic Tremor Masquerading as Essential Tremor
07:30 AM - 12:00 PM Abstract 142 - A Comparison of Pre- and Post-Operative Tremor Medications in Deep Brain Stimulation for Essential Tremor
07:30 AM - 12:00 PM Abstract 144 - Gamma Knife Radiosurgery for Intractable Tremors: Clinical Outcome for 45 Patients
07:30 AM - 12:00 PM Abstract 145 - Impaired Pentagon Drawing Is an Early Indication of Impending Cognitive Decline in Parkinson Disease
07:30 AM - 12:00 PM Abstract 146 - Association between Motor and Nonmotor Symptoms in Patients with Parkinson's Disease (PD): A Post Hoc Analysis of the Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine (RECOVER) Study
07:30 AM - 12:00 PM Abstract 147 - Very Long Term Parkinson[acute]s Disease
07:30 AM - 12:00 PM Abstract 148 - Anterocollis, the Dropped Head Syndrome: Significance and Treatment
07:30 AM - 12:00 PM Abstract 149 - Postural Abnormality in Parkinson's Disease Is a Risk Factor for Leg Deep Vein Thrombosis
07:30 AM - 12:00 PM Abstract 150 - Social Effect of Dyskinesias in Patients with Parkinson Disease and Their Caregivers
07:30 AM - 12:00 PM Abstract 151 - The Course of Multiple Motor and Non-Motor Symptoms in Parkinson's Disease Is Influenced by the Side and Type of Motor Symptoms at Disease Onset
07:30 AM - 12:00 PM Abstract 152 - A Longitudinal Study of Progression and Mortality in a Cohort of Chinese Parkinson's Disease (PD) Patients
07:30 AM - 12:00 PM Abstract 153 - Economic Value of Slowing Parkinson's Disease: Modeling Progression through Hoehn and Yahr Stages
07:30 AM - 12:00 PM Abstract 154 - Costs to Private Insurers for Patients with Early and Advanced Parkinson's Disease
07:30 AM - 12:00 PM Abstract 155 - Gene Expression Signature for Predicting High Versus Low Risk of Future Autoimmune Central Nervous System Attack
07:30 AM - 12:00 PM Abstract 157 - CD24 Polymorphisms and Their Relationship to Multiple Sclerosis in Argentina's Population
07:30 AM - 12:00 PM Abstract 158 - SNPs Associated with Saudi Familial Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 159 - Longitudinal Neurocognitive Outcome in Pediatric-Onset Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 160 - HLA-DR Allele Polymorphism and Multiple Sclerosis in Chinese: A Meta-Analysis
07:30 AM - 12:00 PM Abstract 161 - Genome Wide Expression Study for Potential Biomarkers of Multiple Sclerosis in Patients with Optic Neuritis
07:30 AM - 12:00 PM Abstract 162 - Interleukin-7 Receptor alpha Gene Polymorphism Influences Multiple Sclerosis Risk in Asians
07:30 AM - 12:00 PM Abstract 163 - Obesity as a Risk Factor in Pediatric Demyelinating Disorders
07:30 AM - 12:00 PM Abstract 164 - Evaluation of IFN Beta-1a Induction of miRNA/mRNA in Healthy Control Subjects Using a Novel High-Throughput Whole-Blood Expression-Profiling Method
07:30 AM - 12:00 PM Abstract 165 - Unusual Presentations of Concurrent Central and Peripheral Nervous System Demyelination in Children
07:30 AM - 12:00 PM Abstract 166 - Characteristics of Pediatric MS in South Central US
07:30 AM - 12:00 PM Abstract 167 - ABCD1 Deficiency Impairs the Innate Immune Response: Implications for Brain Demyelination
07:30 AM - 12:00 PM Abstract 168 - Dysregulated Gene Expression Pattern of Anti-Inflammatory Transcripts in Monocytes and T-Lymphocytes from Patients with Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 169 - IFNb-1b Regulates the Expression of a GTPase Activating Protein (RGS1) That Controls Responsiveness to Chemoattractant Receptors and Is Part of an MS Susceptibility Loci
07:30 AM - 12:00 PM Abstract 170 - Laquinimod Skews Monocytes to a Regulatory Phenotype and Modulates Autoimmune Demyelination Via Brain Derived Neurotrophic Factor
07:30 AM - 12:00 PM Abstract 171 - Cyclophilin D Inactivation Modulates Mitochondrial Ca2+ Responses Induced by Oxidative Stress: Implications for the Pharmacologic Inactivation of Cyclophilin D for the Treatment of Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 172 - Effects of Glatiramer Acetate on the B Cell Cytokine Production through Activation of Toll like Receptors
07:30 AM - 12:00 PM Abstract 173 - A Unique T Cell Subset, Th40, Are Pathogenic and Diagnostic in Mulitple Sclerosis
07:30 AM - 12:00 PM Abstract 174 - Investigating the Relationship Between Cladribine-Mediated Changes in Lymphocyte Counts and Clinical/Magnetic Resonance Imaging Outcomes in Patients with Relapsing-Remitting Multiple Sclerosis: Correlation Analyses from the Double-Blind, 96-week CLARITY Study
07:30 AM - 12:00 PM Abstract 175 - Phenotype and Functional Properties of Monocytes from Patients under Laquinimod, a Novel Oral Therapy for the Treatment of Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 176 - Identification of Th1 Type Regulatory T Cells in Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 177 - Interferon-Beta 1a Modulation of B-Cell Costimulatory Function: Implications for Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 178 - Effects of Long-Term FTY720 Therapy on Circulating Natural Killer Cells in Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 179 - Immune Response during Interferon-beta 1b Treatment in Patients with Multiple Sclerosis Who Experienced Relapses and Those Who Were Relapse-Free in the (Success of Titration, Analgesics, and BETA Nurse Support on Acceptance Rates to Early MS Treatment with Betaseron) START Study
07:30 AM - 12:00 PM Abstract 180 - The Effects of Disease Activity and Interferon-beta on Telomere Length and Telomerase Activity in Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 181 - Analysis of the Immunogenicity of an Interferon [beta]1a Follow on Biopharmaceutical
07:30 AM - 12:00 PM Abstract 182 - Flow Cytometry of Natalizumab Binding to Immune Cells and Its Potential Use for Monitoring Disease Activity and Treatment Response in Patients with Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 183 - BG-12 (Dimethyl Fumurate): A Novel Therapeutic To Promote Oligodendrocyte Survival?
07:30 AM - 12:00 PM Abstract 184 - Mechanisms of Laquinimod in Reducing the Accumulation of Monocytoid Cells in the CNS
07:30 AM - 12:00 PM Abstract 185 - Daclizumab Therapy Effectively Blocks CD25 and Expands Immunoregulatory CD56bright NK Cells in the Intrathecal Compartment
07:30 AM - 12:00 PM Abstract 186 - Adrenocorticotrophic Hormone (ACTH) Modulates Antigen Presenting Cell Phenotype and Function in Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 187 - Highly Reactive Anti-MOG Antibodies Differentiate Demyelinating Diseases from Viral Encephalitis in Children
07:30 AM - 12:00 PM Abstract 188 - PBMCs from RRMS Patients That Respond to Glatiramer Acetate Secrete Higher Levels of Inflammatory Cytokines Prior to Treatment
07:30 AM - 12:00 PM Abstract 189 - Soluble Vascular Cell Adhesion Molecule (sVCAM) Levels and Herpes Zoster as Surrogate In Vivo Markers for Cell-Mediated Antiviral Immune Activity in a Natalizumab-Treated Population
07:30 AM - 12:00 PM Abstract 191 - Long Term Immunomodulatory Effects of Cladribine In Vitro: Predominant Induction of TH2 Type Cytokines
07:30 AM - 12:00 PM Abstract 193 - The Effects of Hypothermia on Proinflammatory Cytokines and Nitric Oxide in Patients with Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 194 - SlanDC - Key-Player in Pathogenesis and Treatment in Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 195 - Impaired CD56brightCD16- Natural Killer Cell Function in Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 196 - The Effect of Laquinimod on Immune Cell Compartment
07:30 AM - 12:00 PM Abstract 198 - Changes in Immune Parameters Following Commencement of Laquinimod, a Novel Oral Therapy for the Treatment of Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 199 - Plasmacytoid Dendritic Cells Are Increased in Cerebrospinal Fluid of Untreated Multiple Sclerosis Patients during Relapse
07:30 AM - 12:00 PM Abstract 200 - Deficient Endogenous Interferon beta Signaling Is Associated with Pathogenic Cytokines Secretion Profile from Monocytes and CD4+ T-Cells in Patients with Multiple Scleroisis
07:30 AM - 12:00 PM Abstract 201 - Analysis of Innate Immune Cells Following Alemtuzumab Treatment in Human CD52 Transgenic Mice
07:30 AM - 12:00 PM Abstract 202 - Natural Course of Neurological Manifestations in Xeroderma Pigmentosum Group A (XPA)
07:30 AM - 12:00 PM Abstract 203 - Trends in Outcomes, Severity and Hospitalization Costs among Traumatic Brain Injury in Pediatric Patients in the United States
07:30 AM - 12:00 PM Abstract 204 - Trends in Outcomes, Severity and Hospitalization Costs among Pediatric Traumatic Spinal Cord Injury Patients in the United States
07:30 AM - 12:00 PM Abstract 205 - A Comparison of Open Attribution and Structured Historic Questionnaires by Teachers in the Referral for Evaluation of Attention Disorders: Influences of Ethnicity, Gender, and Socioeconomic Status on Teacher Attribution
07:30 AM - 12:00 PM Abstract 206 - First Trimester Nicotine Exposure and the Risk of Infantile Colic: The Danish National Birth Cohort
07:30 AM - 12:00 PM Abstract 207 - Status of Primary and Comprehensive Stroke Centers in the United States
07:30 AM - 12:00 PM Abstract 208 - Transient Global Amnesia in the Community: Framingham Heart Study
07:30 AM - 12:00 PM Abstract 209 - Lipoprotein Associated Phospholipase A2 (Lp-PLA2) and Cerebral Microbleeds: The Framingham Heart Study
07:30 AM - 12:00 PM Abstract 210 - BRookly AWAreness of StRokE (B-AWARE Study)
07:30 AM - 12:00 PM Abstract 211 - Stroke Incidence, Prognosis and Risk Factors in Young and Middle-Aged Adults. The North Dublin Population Stroke Study
07:30 AM - 12:00 PM Abstract 212 - Risk Factors and Case-Fatality for Stroke in Brazil: A Hospital-Based Registry
07:30 AM - 12:00 PM Abstract 213 - Factors Influencing Hospital Length of Stay in Ischemic Stroke Patients
07:30 AM - 12:00 PM Abstract 214 - The Effect of Depression on Treatment Cost of Stroke: An Analysis by Race and Gender
07:30 AM - 12:00 PM Abstract 215 - Mild Renal Dysfunction Is Related with Short and Long-Term Cognitive Impairment in Ischemic Stroke Patients
07:30 AM - 12:00 PM Abstract 216 - A Closer Look at Transient Ischemic Attack (TIA) Readmissions at an Inner City Hospital
07:30 AM - 12:00 PM Abstract 217 - LDL and Non-HDL Cholesterol and Subtypes of Ischemic Stroke
07:30 AM - 12:00 PM Abstract 218 - Lower Triglycerides Correlate with Increased Admission ICH Score and Worse Outcomes in Spontaneous Intracerebral Hemorrhage
07:30 AM - 12:00 PM Abstract 219 - Patients with Higher HDL Levels Have More Severe Intracerebral Hemorrhages, Larger Hematomas and Have Poorer Outcomes
07:30 AM - 12:00 PM Abstract 220 - Is Stroke of Undetermined Etiologies Different from Stroke of Determined Etiologies?
07:30 AM - 12:00 PM Abstract 221 - Stroke Risk Factors in a Young Adult Population
07:30 AM - 12:00 PM Abstract 222 - Comparison of Atherosclerotic Risk Factors and Physical Factors between Patients with Intracranial Artery Stenosis and Extracranial Carotid Stenosis
07:30 AM - 12:00 PM Abstract 223 - Trends in Outcome and Hospitalization Cost among Adult Patients with Acute Ischemic Stroke and Autonomic Dysfunction in the United States
07:30 AM - 12:00 PM Abstract 224 - The Cost of an Acute Ischemic Stroke Workup Is Affected by Preexisting Risk Factors
07:30 AM - 12:00 PM Abstract 225 - Postoperative Stroke: A Retrospective Analysis of Risk Factors
07:30 AM - 12:00 PM Abstract 226 - Increased Mortality of Thrombolysis for Treatment of Acute Stroke and Atrial Fibrillation: Analysis of the Nationwide Inpatient Sample
07:30 AM - 12:00 PM Abstract 227 - Accuracy of the New ICD-9 Code for "Drip-and-Ship" Thrombolytic Treatment in Patients with Ischemic Stroke. An Analysis of Minnesota Stroke Registry
07:30 AM - 12:00 PM Abstract 228 - Racial Disparities of Stroke Prevention and Treatment
07:30 AM - 12:00 PM Abstract 229 - Does Helicopter Emergency Medical Service Transfer Offer Benefit to Stroke Patients?
07:30 AM - 12:00 PM Abstract 230 - A Tale of Two Healthcare Systems: Disparities in Demographics and Clinical Characteristics between Two Ischemic Stroke Patient Populations Encountered in Los Angeles County
07:30 AM - 12:00 PM Abstract 231 - Factors Associated with 30-Day Readmission in Patients with Stroke and Cerebrovascular Disease
07:30 AM - 12:00 PM Abstract 232 - Cost-Effectiveness Analysis of Intracranial Stent Placement Versus Contemporary Medical Management in Patients with Symptomatic Intracranial Artery Stenosis
07:30 AM - 12:00 PM Abstract 233 - Framingham Coronary Risk Profile Predicts Poorer Executive Functioning in Older Nondemented Adults
07:30 AM - 12:00 PM Abstract 235 - Insulin Resistance Is Related with Small Vessel Disease
07:30 AM - 12:00 PM Abstract 236 - The Ratio of Serum Paraoxonase to Arylesterase Activity (PON/ARE) as a Predictor of Outcome in Ischemic Stroke Patients during 1-Year Follow-Up
07:30 AM - 12:00 PM Abstract 238 - Anterior-to-Posterior Circulation Approach for Mechanical Thrombectomy of an Acutely Occluded Basilar Artery (BA) Using the Penumbra Aspiration System
07:30 AM - 12:00 PM Abstract 239 - Intra-Arterial Tirofiban during Intra-Arterial Thrombolysis of Acute Ischemic Stroke: Preliminary Study
07:30 AM - 12:00 PM Abstract 240 - Patients with Acute Ischemic Stroke and TIA Receive Earlier Anti-Platelet Therapy If a Loading Dose Is Prescribed
07:30 AM - 12:00 PM Abstract 241 - The Outcome of Hyperbaric Oxygen Therapy in Acute Ischemic Stroke
07:30 AM - 12:00 PM Abstract 242 - Resident Initiated Alteplase (rt-PA) Administration in Acute Ischemic Stroke: A Comparison with National Data
07:30 AM - 12:00 PM Abstract 243 - Safety of Stimulants in Post-Stroke Patients in the Sub-Acute Setting
07:30 AM - 12:00 PM Abstract 244 - "Door-to-Needle" Time and Stroke Treatment Strategies
07:30 AM - 12:00 PM Abstract 245 - Recanalization Rates and Outcomes with Larger Diameter Thromboaspiration Catheter in Acute Stroke
07:30 AM - 12:00 PM Abstract 246 - Distal Thrombus Migration with IVtPA Can Be Resistant to Subsequent Endovascular Therapy: A Case Series
07:30 AM - 12:00 PM Abstract 247 - Eligibility Determinations by "Witnessed Onset" and "Last Seen Normal" Principles Are Not the Same among Acute Ischemic Stroke Patients Undergoing Endovascular Treatment
07:30 AM - 12:00 PM Abstract 248 - Decompressive Craniectomy in Patients with Malignant Hemispheric Infarction: A Quality of Life and Functional Outcomes Study in Young and Elderly Patients
07:30 AM - 12:00 PM Abstract 249 - Acute Stroke: Basic Concepts of Thrombolytic Therapy and Hypertension Managemenet by Doctors in the Prehospital Setting
07:30 AM - 12:00 PM Abstract 250 - Cost Differences of Ischemic Stroke and TIA Patients According to Their Age
07:30 AM - 12:00 PM Abstract 252 - Hemorrhage, Recanalization, and Clinical Outcomes for Combined Intravenous and Intraarterial Thrombolysis for Acute Ischemic Stroke
07:30 AM - 12:00 PM Abstract 253 - Acquired Periodic Hypothermia Due to Ischemic Stroke
07:30 AM - 12:00 PM Abstract 254 - Peripheral Leukocyte Counts and Outcomes after Intracerebral Hemorrhage
07:30 AM - 12:00 PM Abstract 255 - Initial Ischemic Stroke Severity Is a Better Predictor of Clinical Outcomes in Anterior Circulation Strokes When Compared to Posterior Circulation Strokes
07:30 AM - 12:00 PM Abstract 256 - Initial NIH Stroke Scale in Patients with Small Vessel Strokes Have Stonger Correlation with Functional Outcomes
07:30 AM - 12:00 PM Abstract 257 - Comparison of Functional Outcome of Total and Partial Occlusionn of MCA
07:30 AM - 12:00 PM Abstract 258 - Is There an Age Differential between Outcomes of Carotid Angioplasty and Stent Placement and Carotid Endarterectomy in General Practice?
07:30 AM - 12:00 PM Abstract 259 - Myocardial Infarctions Following Carotid Stenting and Endarterectomy: Results from the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
07:30 AM - 12:00 PM Abstract 260 - Initial Safety Versus Clinical Durability after Stenting and Endarterectomy: Results from the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST)
07:30 AM - 12:00 PM Abstract 261 - Clinical Relevance of Residual Stenosis Following Intracranial Angioplasty and/or Stent Placement for Atherosclerotic Lesions
07:30 AM - 12:00 PM Abstract 262 - Angioplasty with Stent for Radiation-Induced Extra-Cranial Stenosis
07:30 AM - 12:00 PM Abstract 263 - Safety of Carotid Stenting and Endarterectomy in Symptomatic and Asymptomatic Patients: Results from the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST)
07:30 AM - 12:00 PM Abstract 264 - Is Availability of Emergent Intracranial Endovascular Intervention Required for Carotid Artery Stent Procedures in Contemporary Practice?
07:30 AM - 12:00 PM Abstract 265 - Combination of Neurovascular Imaging Modalities for Evaluation of Patients with Stroke
07:30 AM - 12:00 PM Abstract 266 - Long-Term Clinical and Angiographic Outcomes in Patients with Cervico-Cranial Dissections Treated with Stent Placement - A Meta Analysis of Case Series
07:30 AM - 12:00 PM Abstract 267 - Impact of Glycemic Control on Outcome of Critically Ill Neuromuscular Patients
07:30 AM - 12:00 PM Abstract 268 - Trends in Outcomes and in Severity, Hospitalization Costs and Outcomes among Adult Patients with Traumatic Brain Injury in the United States
07:30 AM - 12:00 PM Abstract 269 - Usefulness of Pulmonary Function Tests and Blood Gases in Acute Neuromuscular Respiratory Failure
07:30 AM - 12:00 PM Abstract 270 - Dexmedetomidine Does Not Increase Vasospasm in Subarachnoid Patients
07:30 AM - 12:00 PM Abstract 271 - Local Application of Botulinum Toxin Type A in Patients with Spastic Quadriparesis and Secondary Upper Respiratory Tract Airway Obstruction: A Therapeutic Alternative for Clinically Indicated Tracheotomy
07:30 AM - 12:00 PM Abstract 272 - High NIHSS Values Predict Significant Impairment of Cardiovascular Autonomic Function
07:30 AM - 12:00 PM Abstract 273 - Trends in Outcome and Cost of Hospitalization of Adult Mechanically Ventilated Guillain-Barre Syndrome Treated with Plasmapheresis
07:30 AM - 12:00 PM Abstract 274 - Trends in Outcome and Cost of Hospitalization of Adult Mechanically Ventilated Guillain-Barre Syndrome Patients Treated Intravenous Immunoglobulin
07:30 AM - 12:00 PM Abstract 275 - Association between Time Spent in the Emergency Department and Stroke Outcome
07:30 AM - 12:00 PM Abstract 276 - Single Brain Death Examination Does Not Improve Organ Transplantation but Costs Less
07:30 AM - 12:00 PM Abstract 277 - Hurst's Disease Mimicking a Cerebral Abscess
07:30 AM - 12:00 PM Abstract 278 - Guillain-Barr[eacute] Syndrome Following a Human Bite
07:30 AM - 12:00 PM Abstract 279 - Cognitive and Psychiatric Outcomes after Carbon Monoxide Exposure during a Storm
07:30 AM - 12:00 PM Abstract 280 - Bilateral Thalamic Infarcts in an Infant with West Syndrome Secondary to ACTH
07:30 AM - 12:00 PM Abstract 281 - Auto-Resuscitation Following Asystole in Acute Brain Injured Patients Being Considered for Organ Donation
07:30 AM - 12:00 PM Abstract 282 - Paroxysmal Hyperactivity Syndrome after Fat Emboli with Good Outcome
07:30 AM - 12:00 PM Abstract 283 - Combat vs. Non-Combat Related Traumatic Brain Injury (TBI) in U.S. Service Members in Iraq: Performance on Neurological Examination and the MACE (Military Acute Concussion Examination)
07:30 AM - 12:00 PM Abstract 284 - Good Outcome with Aggressive Treatment of HELLP Syndrome Associated with Intraparenchymal Bleeding: Case Report and Literature Review
07:30 AM - 12:00 PM Abstract 285 - High Strain-Rate Testing of Brain Tissue Slices: Blast-Induced Traumatic Brain Injury
07:30 AM - 12:00 PM Abstract 286 - A Case of Toxic Leukoencephalopathy Following General Anesthesia: A Newly Described Association?
Faculty Disclosures
Alexandra Carter, MD No disclosure on file
Konstantin E. Balashov, MD, PhD, FAAN Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Florian Eichler, MD An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atlas Venture. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leal Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orchard Tx. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Therapeutics. The institution of Dr. Eichler has received research support from ASPA Therapeutics. The institution of Dr. Eichler has received research support from Abbvie. The institution of Dr. Eichler has received research support from Ionis Pharmaceuticals.
Jun-ichi Kira, MD, PhD Dr. Kira has nothing to disclose.
Bernhard Hemmer, MD No disclosure on file
Valerie Askanas, MD, PhD, FAAN No disclosure on file
Mario A. Saporta, MD, PhD, FAAN Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SwanBio. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharnext. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therapeutics.
David N. Herrmann, MD, FAAN Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acceleron. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint global. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Herrmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Herrmann has received intellectual property interests from a discovery or technology relating to health care.
Yousef Mohammad, MD No disclosure on file
Salvador Cruz-Flores, MD, FAAN The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Anna Nogalska, PhD No disclosure on file
No disclosure on file
Adriano Chio, MD, FAAN Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Brandy R. Matthews, MD, FAAN No disclosure on file
Michael E. Shy, MD, FAAN Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics.
Kenkichi Nozaki, MD No disclosure on file
Camilo E. Fadul, MD, FAAN No disclosure on file
Virgilio Gerald H. Evidente, MD, FAAN Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen.
Mark Keegan, MD, FAAN Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.
Anand Vaishnav, MD No disclosure on file
Jeffrey Waugh, MD, PhD, FAAN Dr. Waugh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Two independent law firms. The institution of Dr. Waugh has received research support from AAN.
Fiona E. Costello, MD Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Accure Therapeutics. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for the Sumaira Foundation.
Alfredo Damasceno, MD No disclosure on file
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Peter Rieckmann, MD, FAAN No disclosure on file
Marcelo A. Kauffman, MD No disclosure on file
Vincent Meininger, MD, PhD No disclosure on file
Ralf Linker Dr. Linker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Linker has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Linker has received research support from Novartis. The institution of Dr. Linker has received research support from Biogen.
W. K. Engel, MD, FAAN No disclosure on file
J. Americo M. Fernandes, Jr., MD, FAAN Dr. Fernandes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Columbia University. The institution of Dr. Fernandes has received research support from MGH philanthropy (Clene, Seelos, UCB, Biohaven, Prilenia, Denali Therapeutics, Calico Life Sciences. The institution of Dr. Fernandes has received research support from Columbia University. The institution of Dr. Fernandes has received research support from PTC Therapeutics. The institution of Dr. Fernandes has received research support from Clene.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Jasmina Ivanova No disclosure on file
Alexis Elbaz, MD No disclosure on file
John Corboy, MD, FAAN Dr. Corboy has received personal compensation for serving as an employee of U of Coloado. Dr. Corboy has received personal compensation for serving as an employee of Rocky Mountain MS Center. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Corboy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mylan. The institution of Dr. Corboy has received research support from MedDay. The institution of Dr. Corboy has received research support from Novartis. The institution of Dr. Corboy has received research support from NMSS. The institution of Dr. Corboy has received research support from PCORI. The institution of Dr. Corboy has received research support from EMD Serono.
Douglas W. Scharre, MD, FAAN Dr. Scharre has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BrainTest, Inc. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Scharre has received research support from InSightec. The institution of Dr. Scharre has received research support from Alzheimer's Therapeutic Research Institute (ATRI). The institution of Dr. Scharre has received research support from Eisai. The institution of Dr. Scharre has received research support from vTv Therapeutics. The institution of Dr. Scharre has received research support from National Institute of Health. The institution of Dr. Scharre has received research support from Eli Lilly. The institution of Dr. Scharre has received research support from Biogen. The institution of Dr. Scharre has received research support from Roche. The institution of Dr. Scharre has received research support from Percision Medicine. The institution of Dr. Scharre has received research support from Premier Research Group. The institution of Dr. Scharre has received research support from Genetch. The institution of Dr. Scharre has received research support from Avanir. The institution of Dr. Scharre has received research support from Cerevel Therapeutics. The institution of Dr. Scharre has received research support from Janssen. The institution of Dr. Scharre has received research support from Cassava. The institution of Dr. Scharre has received research support from UniQure. The institution of Dr. Scharre has received research support from Cognition Therapeutics. The institution of Dr. Scharre has received research support from Cognitive Research Corporation. The institution of Dr. Scharre has received research support from EIP. The institution of Dr. Scharre has received research support from Cognito. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care.
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Cristina Moglia Cristina Moglia has nothing to disclose.
Frank Mastaglia No disclosure on file
Peter Wipfler Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Edward Kim, MD Dr. Kim has nothing to disclose.
Hector R. Martinez, MD Dr. Martinez has nothing to disclose.
Friedemann Paul Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Rebecca Spain, MD, MSPH, FAAN Dr. Spain has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Spain has received research support from Department of Veterans Affairs. The institution of Dr. Spain has received research support from National Multiple Sclerosis Society.
Leslie P. Weiner, MD No disclosure on file
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Sasha Zivkovic, MD, FAAN Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Zivkovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therapeutics. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG Clinical services.
Kerstin Hellwig Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Joseph Giuffrida, PhD No disclosure on file
Per Solberg Sorensen, MD, PhD, FAAN Dr. Sorensen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA.
Anthony Reder, MD Dr. Reder has nothing to disclose.
Martin Savard, MD No disclosure on file
Gordon A. Irving, MD No disclosure on file
Joseph H. Friedman, MD, FAAN No disclosure on file
P. D. Charles, MD, FAAN Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceraxis. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Charles has stock in Arena Therapeutics. The institution of Dr. Charles has received research support from Pharma 2 B. The institution of Dr. Charles has received research support from Intec. The institution of Dr. Charles has received research support from Merz. The institution of Dr. Charles has received research support from Novartis. The institution of Dr. Charles has received research support from Aeon. The institution of Dr. Charles has received research support from Impax. The institution of Dr. Charles has received research support from AskBio. The institution of Dr. Charles has received research support from BlueRock. The institution of Dr. Charles has received research support from AbbVie. The institution of Dr. Charles has received research support from Ipsen.
Jacoline Bromberg, MD No disclosure on file
Dennis N. Bourdette, MD, FAAN Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Bridget T. Carey, MD No disclosure on file
Pariwat Thaisetthawatkul, MD, FAAN Dr. Thaisetthawatkul has nothing to disclose.
Xuemei Huang, MD, PhD Dr. Huang has received personal compensation for serving as an employee of NIH. Dr. Huang has received personal compensation for serving as an employee of DoD. The institution of Dr. Huang has received research support from NIH.
Paul Wicks, PhD No disclosure on file
Bruce I. Ovbiagele, MD, MSc, FAAN Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Dustin A. Heldman, PhD Dr. Heldman has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies Inc.. Dr. Heldman has stock in Great Lakes NeuroTechnologies. The institution of Dr. Heldman has received research support from NIH.
Robert P. Bowser, PhD An immediate family member of Dr. Bowser has received personal compensation for serving as an employee of nVector, Inc.. Dr. Bowser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MT Pharma USA. Dr. Bowser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Therapeutics. Dr. Bowser has or had stock in nVector.Dr. Bowser has received intellectual property interests from a discovery or technology relating to health care.
Nicole C. Hank, MCR, MHSM No disclosure on file
Jean K. Mah, MD, FRCPC, FAAN Dr. Mah has nothing to disclose.
Daniel Rosenbaum, MD No disclosure on file
Joerg R. Kraus, MD No disclosure on file
Izumi Kawachi, MD, PhD Dr. Kawachi has received personal compensation in the range of $0-$499 for serving as a Consultant for Mochida Pharmaceutical CO., LTD.. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving as a Consultant for Euroimmune. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe Pharma. Dr. Kawachi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis Pharma. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Argenx. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi-Sankyo. Dr. Kawachi has received research support from JSPS KAKENHI. Dr. Kawachi has received research support from MHLW Research Program on Rare and Intractable Diseases. Dr. Kawachi has received research support from Japan Kampo Medicine 好色先生 Foundation.
Alona Muzikansky No disclosure on file
Gudarz Davar, MD No disclosure on file
Susanne Muehlschlegel, MD, MPH, FAAN Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grace Pharmaceuticals Inc.. Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Pharmaceuticals Inc.. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of an immediate family member of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from Johns Hopkins Stimulating and Advancing Anesthesiology & Critical Care Medicine Research (StAAR) Award. The institution of Dr. Muehlschlegel has received research support from Trustees of The Patrick and Catherine Weldon Donaghue Medical Research Foundation. The institution of Dr. Muehlschlegel has received research support from Harkin Family Fund (Johns Hopkins Dept. of Neurology). Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving as a Speaker and Author with 好色先生. Dr. Muehlschlegel has a non-compensated relationship as a Member of Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Muehlschlegel has a non-compensated relationship as a Officer of the Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.
Seward B. Rutkove, MD, FAAN Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Katherine D. Mathews, MD, FAAN Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen.
Jeffrey J. Raizer, MD No disclosure on file
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Omar Malik, MD No disclosure on file
Edgardo Cristiano, MD Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Andrew D. Siderowf, MD Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer-Ingelheim. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for askbio. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for capsida. Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parkinson Study Group. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prilenia. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogastrix. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alerity. Dr. Siderowf has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clintrex. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Siderowf has a non-compensated relationship as a Scientific Advisory Board with NeuroPacs that is relevant to AAN interests or activities.
Scott Johnson No disclosure on file
Vincent Truong, MD Dr. Truong has nothing to disclose.
Mary E. Gerard, MD No disclosure on file
Farrah J. Mateen, MD, PhD, FAAN Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
Zaeem A. Siddiqi, MD, PhD Dr. Siddiqi has nothing to disclose.
Jan Drappatz, MD Dr. Drappatz has stock in Pfizer. Dr. Drappatz has stock in Vertex. Dr. Drappatz has stock in GSK. The institution of Dr. Drappatz has received research support from Servier. Dr. Drappatz has received publishing royalties from a publication relating to health care.
Gabriel Persi Gabriel Persi has nothing to disclose.
Fred D. Lublin, MD, FAAN Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Daniel Martinez-Ramirez, MD Dr. Martinez-Ramirez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Mexico. Dr. Martinez-Ramirez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott Mexico.
Martin K. Nicholas, MD No disclosure on file
Mariela Bettini, MD Dr. Bettini has nothing to disclose.
Yian Gu, PhD The institution of Dr. Gu has received research support from NIH.
Jianhua Yan, PhD No disclosure on file
Marianne De Visser, MD, PhD Dr. De Visser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. De Visser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. De Visser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca.
Amy T. Towfighi, MD Dr. Towfighi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law firms. The institution of Dr. Towfighi has received research support from NIH.
Fumio Kanda, MD, PhD, FAAN No disclosure on file
Darryl C. De Vivo, MD, FAAN Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
Alexandre Eusebio, MD No disclosure on file
Alan Pestronk, MD, FAAN The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext.
Susan E. Hughes No disclosure on file
Kessarin Panichpisal, MD No disclosure on file
Moon-Ku Han, MD, PhD No disclosure on file
Jacqueline Channon-Smith No disclosure on file
Sergio J. Gonzalez No disclosure on file
Teepu Siddique, MD, FAAN No disclosure on file
George Howard, PhD Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer.
Jeffrey A. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Xiang Gao, MD, PhD Dr. Gao has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nutrition Journal. The institution of Dr. Gao has received research support from NIH.
Brenda L. Wong, MD No disclosure on file
Pierre Lozeron No disclosure on file
Frank Laferla, PhD No disclosure on file
Katherine P. Rankin, PhD The institution of Dr. Rankin has received research support from Marcus Foundation.
Herbert B. Newton, MD No disclosure on file
Alison Baird, MBBS, PhD, FRACP, MPH The institution of Dr. Baird has received research support from NIH. The institution of Dr. Baird has received research support from NIH. The institution of Dr. Baird has received research support from Research Foundation of SUNY. Dr. Baird has received intellectual property interests from a discovery or technology relating to health care. Dr. Baird has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Maimonides Medical Center.
Primo M. Delgado, MD Dr. Delgado has nothing to disclose.
Richard S. Nicholas, FRCP Dr. Nicholas has nothing to disclose.
Normand E. Allaire No disclosure on file
Susan T. Iannaccone, MD, FAAN Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AveXis. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. The institution of Dr. Iannaccone has received research support from AveXis. The institution of Dr. Iannaccone has received research support from Biogen. The institution of Dr. Iannaccone has received research support from Sarepta. The institution of Dr. Iannaccone has received research support from PTC Therapeutics. The institution of Dr. Iannaccone has received research support from FibroGen. The institution of Dr. Iannaccone has received research support from ReveraGen. The institution of Dr. Iannaccone has received research support from MDA. The institution of Dr. Iannaccone has received research support from PPMD. The institution of Dr. Iannaccone has received research support from NIH. Dr. Iannaccone has received personal compensation in the range of $0-$499 for serving as a grant reviewer with NIH.
Slawomir Michalak, PhD No disclosure on file
Vijayshree Yadav, MD, FAAN Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb Foundation. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono . The institution of Dr. Yadav has received research support from Department of Veterans Affairs. Dr. Yadav has received research support from NIH. Dr. Yadav has received research support from PCORI. Dr. Yadav has received research support from NMSS. The institution of Dr. Yadav has received research support from Department of Veterans Affairs. The institution of Dr. Yadav has received research support from Tykeson Family Foundation Endowed Professorship.
Robert T. Leshner, MD, FAAN No disclosure on file
Patrick Y. Wen, MD, FAAN Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Diamond . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celularity. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chimerix. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Day One Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genenta. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glaxo Smith Kline . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mundipharma. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvation Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prelude Therapeutics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sagimet. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sapience. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vascular Biogenics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for VBI Vaccines . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Black Diamond . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celularity. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genenta. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Glaxo Smith Kline . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mundipharma. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nuvation Bio. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prelude Therapeutics. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sagimet. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vascular Biogenics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBI Vaccines . Dr. Wen has received research support from Astra Zeneca . Dr. Wen has received research support from Black Diamond . Dr. Wen has received research support from Bristol Meyers Squibb . Dr. Wen has received research support from Celgene. Dr. Wen has received research support from Chimerix. Dr. Wen has received research support from Eli Lily . Dr. Wen has received research support from Erasca. Dr. Wen has received research support from Genentech/Roche . Dr. Wen has received research support from Kazia . Dr. Wen has received research support from MediciNova. Dr. Wen has received research support from Merck. Dr. Wen has received research support from Novartis. Dr. Wen has received research support from Nuvation Bio . Dr. Wen has received research support from Servier. Dr. Wen has received research support from Vascular Biogenics . Dr. Wen has received research support from VBI Vaccines . Dr. Wen has received publishing royalties from a publication relating to health care.
Sheena K. Aurora, MD Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
Macarena Cabrera Serrano No disclosure on file
David D. Adams David D. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALNYLAM. David D. Adams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Bibiana Bielekova, MD, FAAN Dr. Bielekova has received research support from National Institutes of Allergy and Infectious Diseases. Dr. Bielekova has received intellectual property interests from a discovery or technology relating to health care. Dr. Bielekova has received publishing royalties from a publication relating to health care.
Raphael A. Carandang, MD, FAAN Dr. Carandang has nothing to disclose.
Christopher Skidmore, MD Dr. Skidmore has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for SALTZ MONGELUZZI BENDESKY LLC. The institution of Dr. Skidmore has received research support from Neuropace. The institution of Dr. Skidmore has received research support from Jazz Pharmaceuticals. The institution of Dr. Skidmore has received research support from Rapport Therapeutics.
Alex B. Chebl, MD No disclosure on file
Rohit Dhall, MD, FAAN Dr. Dhall has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Best Doctors Inc. Dr. Dhall has stock in Verve Therapeutics Inc. Dr. Dhall has stock in Roche Holding Limited. Dr. Dhall has stock in Enliven Therapeutics Inc. The institution of Dr. Dhall has received research support from Amneal. The institution of Dr. Dhall has received research support from Neuroderm. The institution of Dr. Dhall has received research support from Cerevel Therapeutics. The institution of Dr. Dhall has received research support from Neurocrine. The institution of Dr. Dhall has received research support from Neuraly. The institution of Dr. Dhall has received research support from SPARC. The institution of Dr. Dhall has received research support from Pharma2B. The institution of Dr. Dhall has received research support from Alexion. The institution of Dr. Dhall has received research support from Parkinsons Foundation. The institution of Dr. Dhall has received research support from UCB Pharma. The institution of Dr. Dhall has received research support from Inhibikase Therapeutics. The institution of Dr. Dhall has received research support from Amylyx Pharma.
Thomas G. Brott, MD, FAAN Dr. Brott has nothing to disclose.
Franz Fazekas, MD No disclosure on file
Diana M. Escolar, MD, FAAN No disclosure on file
Jose Luchsinger-Stuart No disclosure on file
Yogeshwar V. Kalkonde, MD No disclosure on file
David Kung No disclosure on file
Kerri S. Remmel, MD, PhD Dr. Remmel has nothing to disclose.
James L. Bernat, MD, FAAN Dr. Bernat has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Physician's Index for Ethics in Medicine. The institution of Dr. Bernat has received research support from National Institutes of Health UL1TR001086. The institution of Dr. Bernat has received research support from National Institutes of Health ME-1609-36174. Dr. Bernat has received publishing royalties from a publication relating to health care.
David S. Saperstein, MD No disclosure on file
Stuart D. Cook, MD, FAAN No disclosure on file
Rodger J. Elble, MD, PhD, FAAN Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage . Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ES Therapeutics. Dr. Elble has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Applied Therapeutics. Dr. Elble has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis.
Wendy E. Kaye, PhD Dr. Kaye has received personal compensation for serving as an employee of McKing Consulting Corporation. Dr. Kaye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for the Protection of Human Research Participants.
Saumya Gill, MD No disclosure on file
Gary Lemack, MD No disclosure on file
Tracy T. Batchelor, MD, MPH Dr. Batchelor has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date, Inc. An immediate family member of Dr. Batchelor has received publishing royalties from a publication relating to health care. Dr. Batchelor has received publishing royalties from a publication relating to health care.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Carla D'Agostino, PhD No disclosure on file
Joost Jongen, MD, PhD No disclosure on file
Steven J. Greenberg, MD No disclosure on file
Todd D. Levine, MD Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
Aaron E. Miller, MD, FAAN Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Amilton A. Barreira, MD No disclosure on file
Suriya A. Jeyapalan, MD, MPH Dr. Jeyapalan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Jeyapalan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Jeyapalan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novocure.
Karen C. Albright, DO, DO, PhD, MS, MPH Dr. Albright has nothing to disclose.
Wolfgang Grisold, MD, FAAN No disclosure on file
Ben Wakerley, MD No disclosure on file
Reuben M. Valenzuela, MD No disclosure on file
Richard Morse, MS No disclosure on file
Masatoyo Nishizawa, MD No disclosure on file
Megan Montgomery No disclosure on file
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Sheryl Martin-Schild, MD, PhD, FAAN No disclosure on file
Yaakov Stern, PhD Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Stern has received intellectual property interests from a discovery or technology relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Juan Ignacio Rojas, MD Dr. Rojas has nothing to disclose.
Nikolaos Scarmeas, MD, FAAN Dr. Scarmeas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Albert Einstein Collego of Medicine. The institution of Dr. Scarmeas has received research support from NovoNordisc. The institution of Dr. Scarmeas has received research support from European Union Horizon Projects. The institution of Dr. Scarmeas has received research support from Hellenic Foundation for Research & Innovation .
Michael D. Hill, MD Dr. Hill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Hill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharma. Dr. Hill has received stock or an ownership interest from Circle Neurovascular.
Georges Naasan, MD Dr. Naasan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genentech .
Suleiman Kojan, MD, FAAN No disclosure on file
Eghosa Omoregie, MD No disclosure on file
Warren D. Lo, MD, FAAN The institution of Dr. Lo has received research support from NIH. Dr. Lo has received publishing royalties from a publication relating to health care.
Alireza Minagar, MD No disclosure on file
Dean M. Wingerchuk, MD, FAAN Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Alvaro Pascual-Leone, MD, PhD, FAAN Dr. Pascual-Leone has received personal compensation for serving as an employee of Linus Health. Dr. Pascual-Leone has received personal compensation for serving as an employee of TI Solutions. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BitBrain. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AscenZion. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroelectrics. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TetraNeuron. Dr. Pascual-Leone has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Linus Health. Dr. Pascual-Leone has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for TI Solutions. Dr. Pascual-Leone has or had stock in TI Solutions. The institution of Dr. Pascual-Leone has received research support from NIH. The institution of Dr. Pascual-Leone has received research support from NSF. The institution of Dr. Pascual-Leone has received research support from Brightfocus Foundation . Dr. Pascual-Leone has received intellectual property interests from a discovery or technology relating to health care. Dr. Pascual-Leone has received publishing royalties from a publication relating to health care.
David K. Urion, MD, FAAN Dr. Urion has nothing to disclose.
Ronald Postuma, MD Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
Holly A. Shill, MD, FAAN Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.
Marwan N. Sabbagh, MD, FAAN Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
John N. Caviness, MD, FAAN Dr. Caviness has nothing to disclose.
Scott R. Plotkin, MD, PhD, FAAN Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Neha Dangayach, MD, FAAN Dr. Dangayach has nothing to disclose.
Murray Grossman, MD, FAAN Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Amirhossein Zangiabadi, MD No disclosure on file
Brett M. Kissela, MD, MS, FAAN The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to AAN interests or activities.
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.
Kevin R. Scott, MD, FAAN No disclosure on file
Joan M. Ohayon Joan M. Ohayon has nothing to disclose.
Eugene C. Lai, MD, PhD, FAAN Dr. Lai has received publishing royalties from a publication relating to health care.
David Shprecher, DO, FAAN Dr. Shprecher has received personal compensation for serving as an employee of Banner Health. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanders+Parks. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medplace. The institution of Dr. Shprecher has received research support from MJFF. The institution of Dr. Shprecher has received research support from Cognition Therapeutics. The institution of Dr. Shprecher has received research support from Biogen. The institution of Dr. Shprecher has received research support from Neuraly. The institution of Dr. Shprecher has received research support from Jazz Pharmaceuticals. The institution of Dr. Shprecher has received research support from Sanofi Aventis. The institution of Dr. Shprecher has received research support from Annovis. The institution of Dr. Shprecher has received research support from Neurocrine. The institution of Dr. Shprecher has received research support from Teva. The institution of Dr. Shprecher has received research support from Nuvelution. The institution of Dr. Shprecher has received research support from EIP Pharma. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson's and MDS. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Parkinson's Movement Disorder Alliance.
Gabrielle Glick No disclosure on file
Robert J. Schwartzman, MD No disclosure on file
Virginia J. Howard, PhD The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
Elan D. Louis, MD, MS, FAAN Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to AAN interests or activities.
Jun Goto, MD, PhD No disclosure on file
De-Hyung Lee, MD No disclosure on file
Stephen B. Shrewsbury, MD Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Freya Kamel, PhD No disclosure on file
Paul Eugene P. Lleva, MD, FAAN Dr. Lleva has nothing to disclose.
Charles H. Adler, MD, PhD, FAAN Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Bart Demaerschalk, MD, MSc, FRCPC, FAAN Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Andrew D. Norden, MD No disclosure on file
Immer Armendariz Betancour Immer Armendariz Betancour has nothing to disclose.
Vineet Punia, MD Dr. Punia has nothing to disclose.
Atul Kalanuria, MD Dr. Kalanuria has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for American Medical Experts. Dr. Kalanuria has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Expertiq.
Alejandro A. Rabinstein, MD, FAAN Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Erika Driver-Dunckley, MD, FAAN Dr. Driver-Dunckley has nothing to disclose.
Lyell K. Jones, MD, FAAN Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a President-Elect with 好色先生. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a Chair of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.
Mauricio F. Farez, MD Dr. Farez has received personal compensation for serving as an employee of Entelai. Dr. Farez has stock in Entelai. The institution of Dr. Farez has received research support from Fundación Sadosky.
Alan Lerner, MD The institution of Dr. Lerner has received research support from Premier applied biosciences. Dr. Lerner has received publishing royalties from a publication relating to health care.
Suhayl S. Dhib-Jalbut, MD, FAAN No disclosure on file
Ryuji Kaji, MD, FAAN Dr. Kaji has nothing to disclose.
Santosh B. Murthy, MD Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CarePoint. Dr. Murthy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Stroke and Neurological disorders. The institution of Dr. Murthy has received research support from National Institutes of Health/NINDS.
Cynthia Joyce No disclosure on file
Emilia M. Gatto, MD, FAAN Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for Bago Argentina. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bago. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Janssen. Dr. Gatto has received research support from Roche. The institution of Dr. Gatto has received research support from CHDI.
Lloyd H. Kasper, MD No disclosure on file
Douglas M. Sproule, MD Dr. Sproule has received personal compensation for serving as an employee of Bridge Bio. Dr. Sproule has received personal compensation for serving as an employee of Novartis, Inc. Dr. Sproule has received stock or an ownership interest from Bridge Bio.
James E. Siegler III, MD Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.
Brian R. Apatoff, MD, PhD No disclosure on file
Richard Jones, MD No disclosure on file
Richard S. Finkel, MD, FAAN Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to AAN interests or activities.
Gregg G. Blevins, MD, FRCP(C) Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffman La-roche. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen Idec. The institution of Dr. Blevins has received research support from Novartis. Dr. Blevins has received research support from Hoffman La-Roche. The institution of Dr. Blevins has received research support from EMD Serono. Dr. Blevins has received research support from Biogen Idec. The institution of Dr. Blevins has received research support from MS society of Canada. The institution of Dr. Blevins has received research support from Canadian Institutes of Health Research .
Michael G. Benatar, MBChB, DPhil, FAAN Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Canopy. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alaunos. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Mitchell S. Elkind, MD, MS, FAAN Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
Daniel H. Lowenstein, MD Dr. Lowenstein has received research support from NIH.
Kaj Blennow Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Julius Clinical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celdara Medical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Co-founder with Brain Biomarker Solutions.
David E. Blum, MD Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
Michael A. De Georgia, MD Dr. De Georgia has nothing to disclose.
Anne D. Yacoub, MD Dr. Yacoub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie.
Carlo Pozzilli Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Heinz Reichmann, MD, FAAN Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wissenschaftsverlag.
Cathy A. Sila, MD, FAAN Dr. Sila has nothing to disclose.
Joseph Hentz No disclosure on file
Charles S. DeCarli, MD, FAAN Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH.
Bruce A. Cree, MD, PhD, MAS, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Andrew Lim, MD Dr. Lim has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Canada.
Johanne M. Kaplan, PhD Dr. Kaplan has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Kaplan has stock in ProMIS Neurosciences. Dr. Kaplan has received intellectual property interests from a discovery or technology relating to health care.
Bruce R. Reed, PhD No disclosure on file
Aron S. Buchman, MD No disclosure on file
Charles D. Smith, MD, FAAN No disclosure on file
Eudocia Q. Lee, MD No disclosure on file
Mahmoud Rayes, MD No disclosure on file
Brian D. Moseley, MD Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has or had stock in UCB.
Kenneth R. Perrine, PhD No disclosure on file
Kamal R. Shah, MD No disclosure on file
Erica Rojas-Bilbao, MD No disclosure on file
Fabiana Ortega No disclosure on file
Leonard van den Berg, MD The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Seemant Chaturvedi, MD, FAHA, FAAN Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.
Jennifer G. Goldman, MD, MS, FAAN Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation Scientific Advisory Board. The institution of Dr. Goldman has received research support from Michael J. Fox Foundation. The institution of Dr. Goldman has received research support from Parkinson's Foundation.
Farah H. Mozaffar, MBBS No disclosure on file
MariaClaudia Vigliani No disclosure on file
Michael D. Kaufman, MD No disclosure on file
Michael Schroeter No disclosure on file
Michael Marnane, MD No disclosure on file
Mustapha A. Ezzeddine, MD, FAAN The institution of Dr. Ezzeddine has received research support from NIH.
Dan M. Mungas, PhD Dr. Mungas has nothing to disclose.
Muhammad F. Suri, MD Dr. Suri has nothing to disclose.
Martha Mann, RN No disclosure on file
Aine P. Merwick, MD The institution of Dr. Merwick has received research support from Irish Institute of Clinical Neuroscience.
Tamer Abdelhak, MD Dr. Abdelhak has nothing to disclose.
Richard Kryscio No disclosure on file
Subasini Dash, MD No disclosure on file
Helena C. Chui, MD The institution of Dr. Chui has received research support from National Institute on Aging .
Julie E. Hammack, MD, FAAN Dr. Hammack has nothing to disclose.
Ignacio F. Casas-Parera, MD, PhD, FAAN Dr. Casas-Parera has received publishing royalties from a publication relating to health care.
James F. Meschia, MD, FAAN The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
Stephanie Weiss No disclosure on file
Khosro Farhad, MD, FAAN Dr. Farhad has nothing to disclose.
Paul J. Massman, PhD No disclosure on file
Eric T. Wong, MD, FAAN Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care.
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
A J. Stoessl, MD, FAAN No disclosure on file
Francois G. Kamar, MD No disclosure on file
Arun Varadhachary, MD, PhD Dr. Varadhachary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Varadhachary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Varadhachary has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Varadhachary has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for legal firms .
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Hiroyuki Ishiura, MD No disclosure on file
Susan B. Bressman, MD, FAAN The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Suzanne Powell, MD Dr. Powell has nothing to disclose.
Judith Aharon-Peretz, MD Dr. Aharon-Peretz has nothing to disclose.
Rachelle S. Doody, MD, PhD Dr. Doody has received personal compensation for serving as an employee of F. Hoffman-LaRoche. Dr. Doody has stock in F. Hoffman-LaRoche.
Jose L. Ruiz-Sandoval, MD Dr. Ruiz-Sandoval has nothing to disclose.
Shree Pandya, DPT No disclosure on file
Antonio M. Omuro, MD, FAAN Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from Denovo Biopharma. The institution of Dr. Omuro has received research support from Ono Pharmaceutical. The institution of Dr. Omuro has received research support from Servier. The institution of Dr. Omuro has received research support from Nanopharmaceuticals. The institution of Dr. Omuro has received research support from Denovo.
Ruggero Capra, MD Dr. Capra has nothing to disclose.
Richard Li, MD No disclosure on file
Francois Ducray No disclosure on file
Aashish Patel, DO No disclosure on file
David Chiu, MD Dr. Chiu has nothing to disclose.
Varun V. Reddy, MD No disclosure on file
Jeffrey L. Bennett, MD, PhD, FAAN Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Lawrence J. Hirsch, MD, FAAN Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.
David A. Bennett, MD Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Yonas E. Geda, MD The institution of Dr. Geda has received research support from NIH.
Mario Halfon No disclosure on file
Jonathan Gooblar No disclosure on file
Jan Thone, MD No disclosure on file
Ariane E. Mackey, MD No disclosure on file
Gregory J. Esper, MD, MBA, FAAN Dr. Esper has or had stock in NeuroOne Medical Technologies, Inc.Dr. Esper has or had stock in Focused Cryo, Inc. The institution of an immediate family member of Dr. Esper has received research support from Centers for Disease Control. The institution of Dr. Esper has received research support from Health and Human Services Assistant Secretary for Preparedness and Response. An immediate family member of Dr. Esper has received publishing royalties from a publication relating to health care.
Ana Claudia Almeida No disclosure on file
James R. Brorson, MD Dr. Brorson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Peer Review Corporation. Dr. Brorson has a non-compensated relationship as a Vascular Neurology Pilot Committee with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Diana Roucoux, MPH No disclosure on file
Kristen Kelly, MD No disclosure on file
Pedro J. Garcia-Ruiz, MD No disclosure on file
Andrew Ji No disclosure on file
Hiroshi Nemoto, MD, PhD No disclosure on file
Isabel Conceicao Isabel Conceicao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Isabel Conceicao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sobi.
Stephen K. Van Den Eeden, PhD Dr. Van Den Eeden has received personal compensation for serving as an employee of Kaiser Permanente Northern California. The institution of Dr. Van Den Eeden has received research support from NIH. The institution of Dr. Van Den Eeden has received research support from Biogen. The institution of Dr. Van Den Eeden has received research support from MJFF. The institution of an immediate family member of Dr. Van Den Eeden has received research support from NIH.
Scott D. Newsome, DO, FAAN Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Steven P. Miller, MDCM, FRCPC No disclosure on file
Jennifer Cruz No disclosure on file
Jacqueline French, MD, FAAN Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to AAN interests or activities.
Claudia Kawas, MD The institution of Dr. Kawas has received research support from NIH.
Serkan Ozakbas, MD Dr. Ozakbas has nothing to disclose.
Virender Bhan, MD Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi.
Claudia Kaiser, MD No disclosure on file
Thomas J. Kaley, MD Dr. Kaley has received publishing royalties from a publication relating to health care.
Joachim M. Baehring, MD, FAAN Dr. Baehring has nothing to disclose.
Gregory A. Jicha, MD, PhD Dr. Jicha has nothing to disclose.
Peter J. Kelly, MD No disclosure on file
Evzen Ruzicka, MD, PhD No disclosure on file
A. Gordon Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US Department of Justice. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lexicon. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Smith has received research support from NIH (NINDS, NIDDK). Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a Study Section with NIH.
Gregory F. Wu, MD, FAAN Dr. Wu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Progentec. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wu has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimmunology. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Department of Justice. The institution of Dr. Wu has received research support from EMD Serono. The institution of Dr. Wu has received research support from Biogen.
Mill Etienne, MD, MPH, FAAN Dr. Etienne has nothing to disclose.
Patricio S. Espinosa, MD, MPH, FAAN Dr. Espinosa has nothing to disclose.
Kelly Sullivan, PhD Dr. Sullivan has received intellectual property interests from a discovery or technology relating to health care.
Gabriele Mora, MD Dr. Mora has nothing to disclose.
Gayle R. Pletsch, MD No disclosure on file
Mariusz Stasiolek, MD Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Sophie Auriacombe Bergeaud, MD No disclosure on file
Lakshmi Nayak, MD Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceutical. An immediate family member of Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BraveBio. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kite/Gilead. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genmab. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curis. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miltenyi. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Nayak has received publishing royalties from a publication relating to health care.
Vicki Shanker, MD, FAAN Dr. Shanker has received personal compensation in the range of $0-$499 for serving as a Consultant for The Insighters.
Daniel J. Berlau, PhD No disclosure on file
James W. Chen, MD, PhD No disclosure on file
L J. Greenfield, Jr., MD, PhD, FAAN Dr. Greenfield has received publishing royalties from a publication relating to health care.
Julian Yang, MD No disclosure on file
Alexa Beiser Alexa Beiser has nothing to disclose.
Katherine H. Noe, MD, PhD, FAAN Dr. Noe has a non-compensated relationship as a committe member, Epilepsy MOC article review pilot with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Richard M. Dubinsky, MD, MPH, FAAN Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals. The institution of Dr. Dubinsky has received research support from NIH/NINDS. Dr. Dubinsky has a non-compensated relationship as a Member, independent data safety monitoring board with Roche that is relevant to AAN interests or activities.
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Suraj Muley, MD, FAAN Dr. Muley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Muley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Muley has received publishing royalties from a publication relating to health care.
Robert Altman, MD Dr. Altman has nothing to disclose.
Teresa Coelho, MD Dr. Coelho has nothing to disclose.
Fadi B. Nahab, MD Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Consultation. Dr. Nahab has received intellectual property interests from a discovery or technology relating to health care.
Brendon P. Boot, MD, MBBS Dr. Boot has received personal compensation for serving as an employee of BlueRock Therapeutics. Dr. Boot has stock in Eyepoint Pharmaceuticals.
Felix Benninger, MD Dr. Benninger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurohelp.
Nauman Tariq, MD Dr. Tariq has received personal compensation for serving as an employee of NC neurological society .
Helenius J. Schelhaas, MD No disclosure on file
Daniel Mielcarz No disclosure on file
Jae Wond Jang, MD No disclosure on file
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Marcelo C. Kremenchutzky, MD, FAAN No disclosure on file
Aleksandra Pikula, MD The institution of Dr. Pikula has received research support from CIHR.
Til Menge, MD, FAAN No disclosure on file
Hidehiro Mizusawa, MD, PhD No disclosure on file
James A. Mortimer, PhD, FAAN No disclosure on file
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Thomas Beach Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Honglei Chen, MD, PhD, FAAN The institution of Dr. Chen has received research support from NIH, . The institution of Dr. Chen has received research support from DoD. The institution of Dr. Chen has received research support from Parkinson's Foundation. The institution of Dr. Chen has received research support from MSU GE and Gibby vs. Parky project.
Faisal Fecto, MD, PhD The institution of Dr. Fecto has received research support from NINDS.
Julien Dumurgier No disclosure on file
Panayiotis N. Varelas, MD, PhD, FAAN Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca -Alexion - Portola. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca- Alexion-Portola. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Varelas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Giammarco, Mullins & Horton P.C. The institution of Dr. Varelas has received research support from Marinus. The institution of Dr. Varelas has received research support from Bayer. Dr. Varelas has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Rep to the RUC meeting with AAN. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving as a Speaker at the Annual Meeting with AAN. Dr. Varelas has a non-compensated relationship as a President - Past President with Neurocritical Care Society that is relevant to AAN interests or activities.
John F. Foley, MD, FAAN The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Takashi Matsukawa, MD No disclosure on file
Nandhagopal Ramachandiran, MBBS, DM, FRCP, FAAN, FANA, FAAN Dr. Ramachandiran has nothing to disclose.
Gregory Norris, MD No disclosure on file
Robert Fekete, MD Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva Neuroscience, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia Pharmaceutical, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Adamas Pharmaceutical, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine Biosciences, Inc.. Dr. Fekete has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal Pharmaceuticals, Inc.. Dr. Fekete has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda Therapeutics, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink, Inc.. The institution of Dr. Fekete has received research support from Lundbeck. Dr. Fekete has received publishing royalties from a publication relating to health care. Dr. Fekete has a non-compensated relationship as a Neurological Working Group Member with Alliance for Patient Access that is relevant to AAN interests or activities.
Erwin Chiquete, MD, PhD No disclosure on file
Sze Wai E. Yeung, MD No disclosure on file
Ingo Kleiter No disclosure on file
Tak H. Tsoi, MD No disclosure on file
Joel Kramer, PhD The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Gisa Ellrichmann No disclosure on file
Damien Ricard, MD No disclosure on file
Kevin Tan, MD, FAAN Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck.
Rosebud O. Roberts, MD No disclosure on file
Shoji Tsuji, MD, PhD The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
Alexis Smirnow No disclosure on file
Jun Shimizu, MD, PhD No disclosure on file
Patricio H. Espinosa Del Pozo, MD No disclosure on file
Michael J. Turner, PhD No disclosure on file
Ameer Hassan, DO Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Derek Johnson, MD Dr. Johnson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix.
Dimitri Psimaras, MD No disclosure on file
Szofia S. Bullain, MD Dr. Bullain has received personal compensation for serving as an employee of F. Hoffmann - La Roche Ltd.. Dr. Bullain has received stock or an ownership interest from F. Hoffmann - La Roche Ltd..
Chun M. Cheung, MRCP No disclosure on file
V V. Vedanarayanan, MD, FRCPC Dr. Vedanarayanan has nothing to disclose.
Chad Carlson, MD, FAAN Dr. Carlson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with US Department of Justice.
Jonathan D. Glass, MD Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apic Bio. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CIRM. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bryan Cave Leighton Paisner. The institution of Dr. Glass has received research support from NIH. The institution of Dr. Glass has received research support from ALS Assoiciation. The institution of Dr. Glass has received research support from Muscular Dystrophy Assoication.
Kavit Shah, MD Dr. Shah has nothing to disclose.
Kamakshi Lakshminarayan, MD, PhD Dr. Lakshminarayan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT Labs. The institution of Dr. Lakshminarayan has received research support from NIH.
Kammant Phanthumchinda No disclosure on file
Martijn Muller, PhD No disclosure on file
Misha-Miroslav Backonja, MD Dr. Backonja has nothing to disclose.
Andrew S. Blum, MD, PhD, FAAN The institution of Dr. Blum has received research support from DOD-Ocean State Research Institute, Inc/NIH. The institution of Dr. Blum has received research support from NSF - SBIR. The institution of Dr. Blum has received research support from Alpert Medical School. The institution of Dr. Blum has received research support from Alpert Medical School. Dr. Blum has received publishing royalties from a publication relating to health care. Dr. Blum has received personal compensation in the range of $500-$4,999 for serving as a Medical Director for Ambulatory Video-EEG LTM services, on behalf of Brown Neurology with United Sleep Diagnostics.
Maria Diaz No disclosure on file
Patrice LaLive, MD Dr. LaLive has nothing to disclose.
Archana Balasubramanian No disclosure on file
Marie De Verdal No disclosure on file
Andres F. Deik Acosta Madiedo, MD, FAAN Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Deik Acosta Madiedo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SPARK-NS. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Manifold Bio. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genus Lifesciences. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus Therapeutics. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. The institution of Dr. Deik Acosta Madiedo has received research support from Teva Pharmaceuticals. The institution of Dr. Deik Acosta Madiedo has received research support from Cerevel Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Prevail Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Lundbeck Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from AskBio. The institution of Dr. Deik Acosta Madiedo has received research support from Annovis Bio. The institution of Dr. Deik Acosta Madiedo has received research support from Ono pharmaceuticals. The institution of Dr. Deik Acosta Madiedo has received research support from Amylyx therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Dystonia Coalition/Dystonia Medical Research Foundation. Dr. Deik Acosta Madiedo has received publishing royalties from a publication relating to health care. Dr. Deik Acosta Madiedo has received publishing royalties from a publication relating to health care. Dr. Deik Acosta Madiedo has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with PeerView CME.
Ole Suhr The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam . The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akces. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam. Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Akcea. The institution of Ole Suhr has received research support from Swedish Heart and Lung Foundation.
Sandra L. Helmers, MD, FAAN No disclosure on file
Michael C. Irizarry, MD Dr. Irizarry has received personal compensation for serving as an employee of Eisai, Inc..
Marilou I. Ching, MD Dr. Ching has nothing to disclose.
Marcos C. Fernandez Suarez, MD No disclosure on file
Jorge Asconape, MD Dr. Asconape has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Asconape has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Lifesciences.
Hurmina Muqtadar, MD No disclosure on file
Abraham N. Lieberman, MD, FAAN No disclosure on file
Nijasri Suwanwela, MD No disclosure on file
Sebastian F. Ameriso, MD Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Hussam A. Yacoub, DO Dr. Yacoub has nothing to disclose.
Jefferson Miley, MD No disclosure on file
Nancy L. Kuntz, MD, FAAN Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Kuntz has received research support from Argenx. The institution of Dr. Kuntz has received research support from Astellas. The institution of Dr. Kuntz has received research support from Biogen. The institution of Dr. Kuntz has received research support from Catalyst. The institution of Dr. Kuntz has received research support from Genentech. The institution of Dr. Kuntz has received research support from Scholar Rock. The institution of Dr. Kuntz has received research support from Regenx-Bio. The institution of Dr. Kuntz has received research support from Solid Biosciences. The institution of Dr. Kuntz has received research support from AMO. The institution of Dr. Kuntz has received research support from Novartis. The institution of Dr. Kuntz has received research support from BioHaven. Dr. Kuntz has received personal compensation in the range of $50,000-$99,999 for serving as a Sarepta Express post gene therapy advisor with Sarepta.
Gioacchino Tedeschi, MD Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Steven E. Bushnell, PhD No disclosure on file
Alberto Maud, MD Dr. Maud has nothing to disclose.
Darwin G. Ramirez-Abreu, MD, FAAN Dr. Ramirez-Abreu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic.
Diogo C. Haussen, MD Dr. Haussen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stryker. Dr. Haussen has received stock or an ownership interest from Viz AI.
Charles A. Nichter, MD No disclosure on file
Daekyung Cho, MD No disclosure on file
Jennifer Liebenthal, MD No disclosure on file
Yong Shi, PhD No disclosure on file
Sophia S. Lee, PhD No disclosure on file
Emily C. De Los Reyes, MD Dr. De Los Reyes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biomarin .
Derrick Blackmore No disclosure on file
David Hasan No disclosure on file
Scott L. Heller, MD No disclosure on file
Kiichi Unoda No disclosure on file
Tatiana Witjas No disclosure on file
Lester Y. Leung, MD Dr. Leung has received research support from NIH.
Craig G. Campbell, MD Dr. Campbell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Campbell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid. The institution of Dr. Campbell has received research support from Biogen. The institution of Dr. Campbell has received research support from Genzyme. The institution of Dr. Campbell has received research support from Acceleron, AMO, Biogen, Sarepta, Wave, PTC, Pfizer, Roche.
Jean P. Azulay, MD Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Jorge D. Correale, MD Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Noriko Isobe, MD Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion Pharma. Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai Pharma . Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe. Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis Pharma. Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda Pharmaceutical. Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichisankyo. Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Isobe has received research support from Chugai Pharmaceutical. The institution of Dr. Isobe has received research support from Kyowa Kirin. The institution of Dr. Isobe has received research support from CSL Behring. The institution of Dr. Isobe has received research support from Boehringer Ingelheim. The institution of Dr. Isobe has received research support from Otsuka Pharma. The institution of Dr. Isobe has received research support from Sumitomo Pharmaceutical . The institution of Dr. Isobe has received research support from Eisai.
Rola Mahmoud, MD Dr. Mahmoud has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics, EMD Serono, Amgen and Sanofi . Dr. Mahmoud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD sorono.
Alexander Tinchon, MD No disclosure on file
Joao R. Fontes, MD No disclosure on file
Michael King No disclosure on file
Lawrence K. Wong No disclosure on file
Alyx B. Porter, MD, FAAN Dr. Porter has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to AAN interests or activities.
David E. Millett, MD, PhD No disclosure on file
Stanley J. Iyadurai, MD, PhD, FAAN Dr. Iyadurai has received personal compensation for serving as an employee of Catalyst Pharmaceuticals. Dr. Iyadurai has received stock or an ownership interest from Catalyst Pharmaceuticals.
Kathleen A. Ryan, RN MSCN No disclosure on file
Akash J. Patel No disclosure on file
Julie A. Parsons, MD Dr. Parsons has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenex. The institution of Dr. Parsons has received research support from AveXis. The institution of Dr. Parsons has received research support from Biogen. The institution of Dr. Parsons has received research support from Scholar Rock. The institution of Dr. Parsons has received research support from Biohaven. The institution of Dr. Parsons has received research support from PTC Therapeutics. The institution of Dr. Parsons has received research support from Novartis.
Marie Theaudin, MD No disclosure on file
Christopher Dardis, MD No disclosure on file
Xinrong Lu, MD, PhD No disclosure on file
Hee Jin Kim, MD No disclosure on file
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Maria Corrada, PhD The institution of Dr. Corrada has received research support from NIH.
Wayne M. Clark, MD Dr. Clark has nothing to disclose.
Peter Sazani, PhD No disclosure on file
Jack P. Antel, MD, FAAN Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to AAN interests or activities.
Andrew McKeon, MD The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Dawn O. Kleindorfer, MD, FAAN Dr. Kleindorfer has nothing to disclose.
Israel Steiner, MD No disclosure on file
Ronald C. Petersen, MD, PhD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
W. C. LaFrance, Jr., MD, MPH, FAAN Dr. LaFrance has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medico-legal work.. The institution of Dr. LaFrance has received research support from Department of Defense. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has a non-compensated relationship as a Steering Committee Member with Xenon that is relevant to AAN interests or activities.
Daniel H. Geschwind, MD, PhD Dr. Geschwind has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Ovid Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AcuraStem, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axial Biotherapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Falcon Computing. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier-Biological Psychiatry. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NYAS. Dr. Geschwind has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Covington& Burling LLP. Dr. Geschwind has stock in none related to talk. The institution of Dr. Geschwind has received research support from CurePSP. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from Rainwater Charitable Foundation. The institution of Dr. Geschwind has received research support from NIMH. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from NIH. The institution of Dr. Geschwind has received research support from The Simons Foundation. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from NIMH. The institution of Dr. Geschwind has received research support from NINDS/NIA. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from NIH/NINDS. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from U of Virginia and NIH/NIMH. The institution of Dr. Geschwind has received research support from NIH. The institution of Dr. Geschwind has received research support from NIH/NHGRI. The institution of Dr. Geschwind has received research support from NIH/NIMH. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care.
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
Antonio Bertolotto, MD, FAAN Dr. Bertolotto has nothing to disclose.
Stefan Schwab, MD Dr. Schwab has nothing to disclose.
Eva Krasulova, MD No disclosure on file
Marta Banach, MD Dr. Banach has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz Pharmaceuticals GmbH. Dr. Banach has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz Pharmaceuticals GmbH. Dr. Banach has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Merz Pharmaceuticals GmbH.
David R. Renner, MD, FAAN Dr. Renner has nothing to disclose.
Hing Lung Ip No disclosure on file
Rodolfo Savica, MD, PhD, FAAN The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Michael R. Frankel, MD The institution of Dr. Frankel has received research support from Nico Corporation, Inc.
Sung B. Lee, MD No disclosure on file
Robert A. Taylor, MD No disclosure on file
Ludwig Kappos, MD, FAAN Dr. Kappos has nothing to disclose.
William L. Severt, MD, PhD Dr. Severt has received personal compensation for serving as an employee of AbbVie. Dr. Severt has stock in AbbVie.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Murali Ramanathan, PhD The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
James L. Frey, MD, FAAN No disclosure on file
Philip A. Wolf, MD, FAAN No disclosure on file
Hideyuki Sawada, MD No disclosure on file
Rakesh Khatri, MD, FAAN Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Surasak Phuphanich, MD, FAAN No disclosure on file
Hugh J. McMillan, MD Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Gene Therapies. Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Gene Therapies. The institution of Dr. McMillan has received research support from Roche.
Saqib A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Maria C. Zurru, MD No disclosure on file
Takafumi Hosokawa No disclosure on file
Jan D. Lunemann, MD No disclosure on file
Johanne Personna-Policard, MD No disclosure on file
Joseph Tarsia, MD Dr. Tarsia has nothing to disclose.
Yohan Jung, MD No disclosure on file
Daniela Visconti No disclosure on file
Anne M. Murray, MD No disclosure on file
Michael J. Schneck, MD, FAAN An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Erik K. Henricson, MPH No disclosure on file
Shafeeq Ladha, MD Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ladha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapa Therapeutics. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ladha has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. The institution of Dr. Ladha has received research support from Biogen. The institution of Dr. Ladha has received research support from Sanofi. Dr. Ladha has received publishing royalties from a publication relating to health care.
Toshiki Fujioka, MD Dr. Fujioka has nothing to disclose.
Gregory Kapinos, MD, MS No disclosure on file
Phillip E. Justice, DO, DBA, MBA, FAAN No disclosure on file
Dennis W. Choi, MD, PhD No disclosure on file
Dileep R. Yavagal, MD, FAAN Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Wei Liu, MD Dr. Liu has nothing to disclose.
Paul E. Schulz, MD Dr. Schulz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisa .
Stefan Oberndorfer, MD No disclosure on file
Björn Tackenberg, MD, FAAN Dr. Tackenberg has received personal compensation for serving as an employee of F. Hoffmann-La Roche AG. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GILEAD. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tackenberg has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Tackenberg has received stock or an ownership interest from F. Hoffmann-La Roche AG. The institution of Dr. Tackenberg has received research support from Biogen. The institution of Dr. Tackenberg has received research support from Novartis. The institution of Dr. Tackenberg has received research support from Roche.
James C. Watson, MD No disclosure on file
Su Hyun Park, MD No disclosure on file
Spozhmy Panezai, MD Dr. Panezai has nothing to disclose.
Kari D. Moore, RN, APRN Ms. Moore has nothing to disclose.
SangYun Kim, MD, PhD No disclosure on file
Ali AlKhathami No disclosure on file
Alexandra Flowers, MD No disclosure on file
Mark Tarnopolsky, MD, PhD, FRCP Dr. Tarnopolsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Tarnopolsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reneo. Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reneo . Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Tarnopolsky has stock in Synaptive Medical. Dr. Tarnopolsky has stock in CloudDx. The institution of Dr. Tarnopolsky has received research support from Canadian Institute for Health Research. Dr. Tarnopolsky has received intellectual property interests from a discovery or technology relating to health care.
Richard S. Young, MD, FAAN Dr. Young has nothing to disclose.
Gustavo J. Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Han-Xiang Deng, MD Dr. Deng has nothing to disclose.
Alice J. Sheffet, PhD No disclosure on file
Bethanie N. Morgan, MD Dr. Morgan has nothing to disclose.
Thomas W. Smith, MD No disclosure on file
Wiley Hall, MD No disclosure on file
Karl M. Meisel, MD No disclosure on file
Mark J. Rametta, DO No disclosure on file
Robert L. Sufit, MD No disclosure on file
Zachary Miller, MD Dr. Miller has nothing to disclose.
Phillip D. Swanson, MD No disclosure on file
Francois Chollet, MD No disclosure on file
Jay C. Kwon, MD No disclosure on file
Eelco F. Wijdicks, MD, FAAN Dr. Wijdicks has received publishing royalties from a publication relating to health care.
Rui Liu, PhD No disclosure on file
Yi Lu No disclosure on file
Haadi Shuaib No disclosure on file
Ioanna Milidou No disclosure on file
Jeffrey Tobias, MD No disclosure on file
Marco R. Fossati-Bellani, MD No disclosure on file
Jeremy Rudnick, MD Dr. Rudnick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
Craig McDonald, MD Dr. McDonald has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.
Helen Shih No disclosure on file
Henrik Zetterberg Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Satoshi Yoshimura, PhD No disclosure on file
Nayoung Kim, MD No disclosure on file
Giovana Femat, MD No disclosure on file
Ryna Then, MD Dr. Then has nothing to disclose.
Richard Abresch No disclosure on file
Melissa Mercado, MD No disclosure on file
Takayasu Fukudome, MD No disclosure on file
Geertrui F. Vanhove, MD, PhD, MBA No disclosure on file
Haitham Hussein, MD, FAAN Dr. Hussein has nothing to disclose.
Jan H. Veldink, MD, PhD The institution of Dr. Veldink has received research support from Biogen.
Sonia Brucki Sonia Brucki has nothing to disclose.
Matthew L. Sherman, MD No disclosure on file
Takuya Matsushita No disclosure on file
Katja Thomas, MD No disclosure on file
Michael M. Tuchman, MD, FAAN No disclosure on file
Liliana B. Patrucco, MD Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Hee-Joon Bae, MD No disclosure on file
Jeremie Pariente No disclosure on file
Ji Hoe Heo, MD, PhD No disclosure on file
Kathy Selby, MD The institution of Dr. Selby has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Selby has received research support from Biogen . The institution of Dr. Selby has received research support from Italfarmico. The institution of Dr. Selby has received research support from Reverogen.
Christophe Tzourio, MD, PhD No disclosure on file
Martin Gizzi, MD, PhD, FAAN No disclosure on file
Kenneth M. Attie, MD No disclosure on file
Tamika M. Burrus, MD, FAAN Dr. Burrus has received personal compensation for serving as an employee of SOC TELEMED.
Mahta Samizadeh No disclosure on file
Daniel Brooks, MD No disclosure on file
Haatem M. Reda, MD Dr. Reda has nothing to disclose.
Marcelo F. Rugiero, MD No disclosure on file
Manpreet Kaur, MD No disclosure on file
Meelee Tom No disclosure on file
Susan W. Law, DO Dr. Law has nothing to disclose.
Senda Ajroud-Driss, MD, FAAN Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astrazeneca. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Ajroud-Driss has received research support from NIH. The institution of Dr. Ajroud-Driss has received research support from University of Minesota/FDA. The institution of Dr. Ajroud-Driss has received research support from Edgewise Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Biogen. The institution of Dr. Ajroud-Driss has received research support from Woolsey Pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Uniqure Biopharma. The institution of Dr. Ajroud-Driss has received research support from Coya Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Novartis. The institution of Dr. Ajroud-Driss has received research support from Alnylam pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Healey and AMG center for ALS . The institution of Dr. Ajroud-Driss has received research support from les Turner ALS Foundation. The institution of Dr. Ajroud-Driss has received research support from Hopewell. The institution of Dr. Ajroud-Driss has received research support from Peripheral neuropathy foundation. Dr. Ajroud-Driss has received publishing royalties from a publication relating to health care.
Daniel Phillips, MD No disclosure on file
Nancy D. Richert, MD, PhD No disclosure on file
Joao O. Siffert, MD No disclosure on file
Natalie P. Valle, MPH No disclosure on file
Ashutosh P. Jadhav, MD, FAAN Dr. Jadhav has nothing to disclose.
Melissa M. Cortez, DO The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
Alexandros L. Georgiadis, MD No disclosure on file
Glenn Lesser No disclosure on file
Eric Molho, MD, FAAN Dr. Molho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Molho has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CNS Ratings. Dr. Molho has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences.
Giancarlo Logroscino, MD, PhD, FAAN Dr. Logroscino has nothing to disclose.
Bernardo Cacho Diaz, MD, FAAN Dr. Cacho Diaz has nothing to disclose.
Massimo Corbo No disclosure on file
Smriti Agrawal, PhD No disclosure on file
Benito P. Damasceno, MD, PhD No disclosure on file
Juan Carlos Gomez Esteban, MD Dr. Gomez Esteban has nothing to disclose.
Edward Croze, PhD No disclosure on file
Mark A. Jensen, PhD No disclosure on file
Ettore Beghi, MD, FAAN No disclosure on file
Shu-Ing Chang No disclosure on file
Helio Afonso G. Teive, MD, PhD, FAAN Dr. Teive has nothing to disclose.
James Sheridan, PhD No disclosure on file
Kourosh Rezania, MD, FAAN Dr. Rezania has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea. Dr. Rezania has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam.
Louise D. McCullough, MD, PhD The institution of Dr. McCullough has received research support from NIH. The institution of Dr. McCullough has received research support from American Heart Association.
Marie Wolanin, MD No disclosure on file
Kallol R. Chaudhuri, MD, FRCP Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acadia, GSK, Scion, Britannia , Lobsor. Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Britannia, Scion, Sunovion, UCB, . Dr. Chaudhuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie, Britannia, UCB, Zambon. Dr. Chaudhuri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NPJ PD journal. The institution of Dr. Chaudhuri has received research support from Britania Pharmaceuticals, AbbVie, UCB, GKC, Bial, Aacdemic grants: EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC, Wellcome Trust.
Nicholas J. Silvestri, MD, FAAN Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of an immediate family member of Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Silvestri has received publishing royalties from a publication relating to health care.
Xin Zhang No disclosure on file
Kimberly Moran, PhD No disclosure on file
Peter Sillevis Smitt, MD The institution of Dr. Sillevis Smitt has received research support from Euroimmun. Dr. Sillevis Smitt has received intellectual property interests from a discovery or technology relating to health care.
Michael Kruer, MD Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC Therapeutics. The institution of Dr. Kruer has received research support from NIH NINDs. The institution of Dr. Kruer has received research support from Medtronic . Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with NHRSA.
Carlos A. Vrech, MD No disclosure on file
Pankaj Satija, MD No disclosure on file
Paisith Piriyawat, MD Dr. Piriyawat has nothing to disclose.
Joni M. Clark, MD No disclosure on file
Tracie Caller, MD, MPH, FAAN Dr. Caller has nothing to disclose.
Raja Mehanna, MD Dr. Mehanna has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Mehanna has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Mehanna has received research support from Cerevel. The institution of Dr. Mehanna has received research support from Neurocrine.
Ericka P. Greene, MD, FAAN Dr. Greene has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis . Dr. Greene has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Abraham & Watkins Texas Law Firm. The institution of Dr. Greene has received research support from National Science Foundaton .
Teresa M. DeAngelis, MD No disclosure on file
Masayuki Tahara, MD, PhD No disclosure on file
Marcy L. Tarrants, PhD, MPA No disclosure on file
Christopher Cunniff, MD No disclosure on file
Elijah Stommel, MD, FAAN Dr. Stommel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Suslick Attorney. The institution of Dr. Stommel has received research support from CDC.
Steven Moore, PhD No disclosure on file
Andrew Solomon, MD, FAAN Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche . Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiniksa Pharmaceuticals . Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Solomon has received research support from Bristol Meyers Squibb.
Carroll William, MD No disclosure on file
Barry G. Arnason, MD No disclosure on file
Yedatore S. Venkatesh, MD, FAAN Dr. Venkatesh has nothing to disclose.
Giuseppe Lanzino, MD Dr. Lanzino has nothing to disclose.
Toby I. Gropen, MD Dr. Gropen has nothing to disclose.
Rut D. Dholakia, MD No disclosure on file
Laura Fratiglioni No disclosure on file
Brett T. Lund, PhD No disclosure on file
Thomas Haberman, MD No disclosure on file
Alexandra L. Czap, MD The institution of Dr. Czap has received research support from SVIN. The institution of Dr. Czap has received research support from AAN.
Jerry J. Shih, MD, FAAN Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Life. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Shih has received research support from Neurona. The institution of Dr. Shih has received research support from NCGS, Inc. Dr. Shih has a non-compensated relationship as a Test Writing Committee Member with ABPN that is relevant to AAN interests or activities.
David K. Chen, MD No disclosure on file
Mimi Sohn, MD No disclosure on file
Eve E. Kelland, PhD No disclosure on file
Ichiro Nakashima, MD, PhD Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Nakashima has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Nakashima has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Nakashima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Nakashima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. The institution of Dr. Nakashima has received research support from LSI Medience. The institution of Dr. Nakashima has received research support from BML.
Lisa R. Rogers, DO, FAAN Dr. Rogers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure .
Jessica Blick No disclosure on file
Magali Perquin No disclosure on file
Masahiro Sonoo No disclosure on file
Deborah Stein No disclosure on file
Eugen Trinka Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Eugen Trinka has received research support from European Union. Eugen Trinka has received publishing royalties from a publication relating to health care.
Walter Taal, MD No disclosure on file
Alexander Dressel, MD No disclosure on file
Wendy Gilmore, PhD No disclosure on file
Angel Vinuela Cabezas De Herrera, MD No disclosure on file
Daphne Wang No disclosure on file
Nutan Sharma, MD, PhD, FAAN Dr. Sharma has nothing to disclose.
Raveen Deol, MD No disclosure on file
Jun Mitsui No disclosure on file
Richard S. Bedlack, MD, PhD, FAAN Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Guidepoint Global. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for New Biotic. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey Pharma. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF Pharma. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe America. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Scicence. Dr. Bedlack has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ALS Association. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adept Field Solutions. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apellis. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Swan. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clarivate. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clean. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CM Group. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corcept. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Healthcare. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maple Health Care. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Association of Managed Care Physicians. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Projects in Knowledge. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shinkei Pharma. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Webb MD/Medscape. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mallinkrodt. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amylyx. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for GenieUS. The institution of Dr. Bedlack has received research support from Cytokinetics. The institution of Dr. Bedlack has received research support from Orion. The institution of Dr. Bedlack has received research support from Ultragenyx. The institution of Dr. Bedlack has received research support from MediciNova. The institution of Dr. Bedlack has received research support from Healey Center. Dr. Bedlack has received publishing royalties from a publication relating to health care.
Clifford B. Saper, MD, PhD, FAAN Dr. Saper has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. The institution of Dr. Saper has received research support from NIH. The institution of Dr. Saper has received research support from Mathers Foundation. The institution of Dr. Saper has received research support from Tsukuba University. Dr. Saper has received publishing royalties from a publication relating to health care. Dr. Saper has received publishing royalties from a publication relating to health care. Dr. Saper has a non-compensated relationship as a Treasurer with American Neurological Association that is relevant to AAN interests or activities.
Elisabetta Pupillo No disclosure on file
Ya-Ping Yang No disclosure on file
Rachel A. Di Trapani, MD No disclosure on file
Kevin N. Sheth, MD, FAAN Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Renato P. Munhoz, MD, PhD Dr. Munhoz has nothing to disclose.
David A. Hafler, MD, FAAN Dr. Hafler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hafler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genetech. Dr. Hafler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Hafler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Joint Commission International.
Elizabeth S. Rowe, PhD, MBA No disclosure on file
Jeremy Abramson Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. Jeremy Abramson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Interius. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seagen. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astra-Zeneca. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Foresight Diagnostics. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miltenyi Biotec. Jeremy Abramson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BeiGene. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Jeremy Abramson has received research support from Allogene. The institution of Jeremy Abramson has received research support from BMS. The institution of Jeremy Abramson has received research support from Genentech. Jeremy Abramson has received research support from Cellectis. The institution of Jeremy Abramson has received research support from Merck.
Anna G. Barsukova, PhD, MS No disclosure on file
Nico J. Diederich, MD No disclosure on file
Germano C. Falcao, MD No disclosure on file
Susan A. Hall, PhD No disclosure on file
Melanie Korsen No disclosure on file
Nidhi Mehta, MD No disclosure on file
Adam Quick, MD The institution of Dr. Quick has received research support from NINDS. The institution of Dr. Quick has received research support from NEALS.
David B. Burtis, DO No disclosure on file
Chethan P. Venkatasubba Rao, MD Dr. Venkatasubba Rao has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Maestro Inc.
Patricia Musolino, MD, PhD An immediate family member of Dr. Musolino has received personal compensation for serving as an employee of EMD Sorono. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Minoryx Pharmaceuticals. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IONIS Pharmaceuticals . Dr. Musolino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inozyme Pharma. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. An immediate family member of Dr. Musolino has or had stock in 2seventy Bio. An immediate family member of Dr. Musolino has or had stock in Editas Medicine. An immediate family member of Dr. Musolino has or had stock in Generation Bio. An immediate family member of Dr. Musolino has or had stock in Beam Therapeutics. An immediate family member of Dr. Musolino has or had stock in Ebotec . An immediate family member of Dr. Musolino has or had stock in Novonordisk. An immediate family member of Dr. Musolino has or had stock in Morphosys. The institution of Dr. Musolino has received research support from National Institute of Health-NINDS-R01. The institution of Dr. Musolino has received research support from Angea Biotherapeutics. The institution of Dr. Musolino has received research support from Minoryx Pharmaceuticals. The institution of Dr. Musolino has received research support from Belanger Foundation. The institution of Dr. Musolino has received research support from Rozwat Family Foundation. The institution of Dr. Musolino has received research support from Dooley Family Foundation. Dr. Musolino has received intellectual property interests from a discovery or technology relating to health care. Dr. Musolino has received publishing royalties from a publication relating to health care.
Evan J. Fertig, MD No disclosure on file
Florian Perez No disclosure on file
Ayushi Chugh, MD, FAAN Dr. Chugh has nothing to disclose.
Vivek Rai, MD Dr. Rai has nothing to disclose.
Siddharth Kaul, MD, PhD No disclosure on file
Bruce Roberts, PhD No disclosure on file
Nicholas Blondin, MD Dr. Blondin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure, Inc.. Dr. Blondin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure, Inc..
Walter A. Rocca, MD, MPH The institution of Dr. Rocca has received research support from National Institute on Aging - NIH. The institution of Dr. Rocca has received research support from National Heart, Lung, and Blood Institute - NIH.
Wendy Mack No disclosure on file
Hisatomo Kowa, MD, PhD No disclosure on file
David G. Munoz, MD No disclosure on file
Peter H. King, MD The institution of Dr. King has received research support from Department of Veterans Affairs. The institution of Dr. King has received research support from NIH.
Olgica Laban-Grant, MD No disclosure on file
Tal Birnberg Tal Birnberg has received personal compensation for serving as an employee of Neuroderm.
Abeer Alsalamah No disclosure on file
Alberto J. Espay, MD, FAAN Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Frederick A. Schmitt, PhD The institution of Dr. Schmitt has received research support from NIH.
James E. Galvin, MD, MPH Dr. Galvin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cognivue. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eisai. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GE Healthcare. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Galvin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PassageBio. The institution of Dr. Galvin has received research support from National Institutes of Health. Dr. Galvin has received intellectual property interests from a discovery or technology relating to health care. Dr. Galvin has a non-compensated relationship as a Board of Directors with Alzheimer Association Southeast Florida Chapter that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Resource Center that is relevant to AAN interests or activities.
Sigal Melamed-Gal No disclosure on file
Masayuki Ochi No disclosure on file
JaNean Engelstad JaNean Engelstad has nothing to disclose.
Christian Baumann, MD No disclosure on file
Felipe Von Glehn Silva, MD, PhD, MSc, FAAN Dr. Von Glehn Silva has nothing to disclose.
Nazli A. Janjua, MD, MBBS Dr. Janjua has nothing to disclose.
Brian P. O'Neill, MD, FAAN No disclosure on file
Timothy E. Lotze, MD, FAAN Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Shruti P. Agnihotri, MD An immediate family member of Dr. Agnihotri has stock in Pfizer. The institution of Dr. Agnihotri has received research support from Roche/ Genentech.
Evelyne Cote-Mantha, MD No disclosure on file
J Renfroe, MD Dr. Renfroe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage Therapeutics. Dr. Renfroe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Renfroe has received intellectual property interests from a discovery or technology relating to health care.
Monika Ummat, MD No disclosure on file
Haralabos Zacharatos, MD Dr. Zacharatos has nothing to disclose.
Nuwan Kurukulasuriya, PhD No disclosure on file
John Probasco, MD, FAAN Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Clinician. The institution of Dr. Probasco has received research support from Roche/Genentech.
Howard S. Derman, MD No disclosure on file
Ximena Morales, MD No disclosure on file
Chunfeng Liu No disclosure on file
Maarten G. Lansberg, MD Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Richard & Connor. Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Keating Jones Hughes. Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Chason, Rosner, Leary & Marshall. Dr. Lansberg has received publishing royalties from a publication relating to health care.
Eoin P. Flanagan, MBBCh, FAAN The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Martin Van Den Bent Martin Van Den Bent has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genenta. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fore Biotherapeutics. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Incyte. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for European Journal of Cancer. Martin Van Den Bent has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuro-Oncology.
Joyce Segers-Van Ryn, MD No disclosure on file
Paul H. Gordon, MD, PhD, FAAN No disclosure on file
Stephen W. Clark, MD, PhD Dr. Clark has nothing to disclose.
Aubrey Adams, PhD Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Viet Nguyen, MD Dr. Nguyen has received personal compensation for serving as an employee of Biogen. Dr. Nguyen has stock in Biogen.
Naveed Akhtar, MD, FAAN Dr. Akhtar has nothing to disclose.
David T. Jones, MD Dr. Jones has stock in Cephlodyne Neurotechnologies, Inc.. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care.
Arnaldo N. Da Silva, MD No disclosure on file
Gyula Acsadi, MD, FAAN Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serepta. Dr. Acsadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Olivier Benveniste, MD, PhD No disclosure on file
Mary Guerriero Austrom, PhD No disclosure on file
Silva Markovic-Plese, MD, FAAN Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Silke Schmidt, PhD No disclosure on file
Giovanni Savettieri, MD No disclosure on file
Arkadiy y. Konyukhov, MD No disclosure on file
William M. Siders, PhD No disclosure on file
Valory Pavlik, PhD The institution of Dr. Pavlik has received research support from Alzheimer's Association.
Joan T. Moroney, MD, MRCPI No disclosure on file
Egemen Idiman, MD No disclosure on file
Michael Olson No disclosure on file
Bagar A. Husaini No disclosure on file
Santosh Kesari, MD, PhD, FAAN Dr. Kesari has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for xcures. Dr. Kesari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Duke.
Snehi Sehgal-Kapur, MD No disclosure on file
Katsuhiko Kohara, MD No disclosure on file
Paolo Ragonese No disclosure on file
Ana Ochoa-Guzman No disclosure on file
Toshihiro Hayashi, MD, PhD No disclosure on file
Izabela Karbassi No disclosure on file
Conrad Weihl, MD, PhD Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Casma therapeutics. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acceleron. Dr. Weihl has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wilson Elser Moskowitz Edelman & Dicker LLP.
Trina Johnson, MD No disclosure on file
William M. Coplin, MD, FCCM No disclosure on file
Frank L. Silver, MD Dr. Silver has nothing to disclose.
Liat Hayardeny Nisimov, PhD No disclosure on file
Pratik D. Bhattacharya, MD, MPH Dr. Bhattacharya has a non-compensated relationship as a Research Advisor with Defeat MSA Alliance 501 (c) (3) that is relevant to AAN interests or activities.
Francois Tison, MD, PhD No disclosure on file
Jesse J. Corry, MD No disclosure on file
Jean-Francois Dartigues, PhD No disclosure on file
Donald P. Smith No disclosure on file
Tejas A. Patel, MBBS, FRACP No disclosure on file
Kenji Kamogawa, MD No disclosure on file
Anupama Kumar, PhD No disclosure on file
Yazhong Tao No disclosure on file
Eric J. Sorenson, MD, FAAN The institution of Dr. Sorenson has received research support from Biogen.
Zachary Simmons, MD, FAAN Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insmed. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from Clene. The institution of Dr. Simmons has received research support from NIH via MGH. The institution of Dr. Simmons has received research support from Aburo. The institution of Dr. Simmons has received research support from NIH subaward via Univ of Pennsylvania.
Robert G. Kaniecki, MD Dr. Kaniecki has nothing to disclose.
Srivadee Oravivattanakul, MD Dr. Oravivattanakul has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Allan G. Kermode, MD, MBBS, FRACP Dr. Kermode has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kermode has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche.
David B. Rosenfield, MD, FAAN No disclosure on file
Maeve H. Dargush, NP No disclosure on file
Paula Rauschkolb, DO No disclosure on file
Leonel Cantu-Martinez, MD Dr. Cantu-Martinez has nothing to disclose.
Vernon D. Rowe, MD, FAAN No disclosure on file
Emiliya Melkumova, MD Dr. Melkumova has nothing to disclose.
Kaavya Narasimhalu, MD, PhD No disclosure on file
Sonia Lal, MD No disclosure on file
Brij M. Singh Ahluwalia No disclosure on file
Mohammed Rehman, DO Dr. Rehman has nothing to disclose.
Roberto M. Velez, MD No disclosure on file
Yaira R. Garzon, MD No disclosure on file
Marcelo E. Lancman, MD No disclosure on file
Archana A. Patel, MD, MPH, MSc Dr. Patel has received research support from NIH/NINDS.
Asif A. Khan, MD No disclosure on file
Larry B. Goldstein, MD, FAHA, FAAN The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Fabio M. Iwamoto, MD No disclosure on file
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
Amer A. Ghavanini, MD Dr. Ghavanini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitisubishi Tanabe Pharm.
Andrew Resnick, BS No disclosure on file
Majaz Moonis, MD, FAHA, FAAN Dr. Moonis has nothing to disclose.
Marco D'Amelio, MD No disclosure on file
Radoslaw Kazmierski, MD, PhD Dr. Kazmierski has nothing to disclose.
Robert Ferguson, MD No disclosure on file
Barbara Agee Shah, NP No disclosure on file
Tokihisa Nagai No disclosure on file
Michiya Igase, MD No disclosure on file
Yoko Okada, MD No disclosure on file
Kenji Sekiguchi, MD, PhD Dr. Sekiguchi has nothing to disclose.
Makiko Taira, MD, PhD No disclosure on file
Tarso Adoni, MD, PhD, FAAN Dr. Adoni has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Shingo Konno, MD Dr. Konno has nothing to disclose.
Eldad Melamed, MD No disclosure on file
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Carlos S. Kase, MD, FAHA, FAAN Dr. Kase has nothing to disclose.
Marc Tardieu, MD No disclosure on file
Max J. Hilz, MD, PhD, FAAN Dr. Hilz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SANOFI. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Claire Riley, MD, FAAN Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Marcia Waddington Cruz, MD Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sobi. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk.
Lorene M. Nelson, PhD Dr. Nelson has nothing to disclose.
Anna Mazzeo, MD Dr. Mazzeo has nothing to disclose.
Susan Shaw, MD No disclosure on file
Gerald E. Grossman, MD No disclosure on file
Adam Webb, MD, FAAN Dr. Webb has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Spears Rebman Moore, Williams PC.
Kevin P. Becker, MD, PhD No disclosure on file
Sakhina Begum-Haque, PhD No disclosure on file
David C. Preston, MD, FAAN Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care.
Sudha Seshadri, MD, FAAN Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.
Francesca Gilli No disclosure on file
Kamala Saha, MD, FAAN Dr. Saha has nothing to disclose.
Tracy Chiem, MD No disclosure on file
Mario Habek, MD Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Elizabeth Macri, MD Dr. Macri has nothing to disclose.
Yazan Alderazi, MD, MB BCh BAO No disclosure on file
Donna Grogan, MD No disclosure on file
Lilith Judd, MD No disclosure on file
Jennifer Takesaka, MD Dr. Takesaka has nothing to disclose.
Ruth Djaldetti, MD No disclosure on file
Amir Khan, MD No disclosure on file
Maria E. Baldwin, MD Dr. Baldwin has nothing to disclose.
Soma Sengupta, MD, PhD, FAAN Dr. Sengupta has received personal compensation in the range of $0-$499 for serving as a Consultant for Novocure. Dr. Sengupta has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Bioventures. Dr. Sengupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. Dr. Sengupta has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bexion. Dr. Sengupta has stock in Amlal. The institution of Dr. Sengupta has received research support from ABTA. Dr. Sengupta has received intellectual property interests from a discovery or technology relating to health care.
Aurauma Chutinet, MD No disclosure on file
Samuel Goldman, MD, MPH Dr. Goldman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Littlepage Booth Leckman. The institution of Dr. Goldman has received research support from Michael J Fox Foundation. The institution of Dr. Goldman has received research support from US Department of Defense. The institution of Dr. Goldman has received research support from US Veterans Administration. The institution of Dr. Goldman has received research support from National Institutes of Health. The institution of Dr. Goldman has received research support from Health Resources and Services Administration. The institution of Dr. Goldman has received research support from American Academy of Pediatrics. Dr. Goldman has received personal compensation in the range of $100,000-$499,999 for serving as a Professor with University of California San Francisco. Dr. Goldman has received personal compensation in the range of $100,000-$499,999 for serving as a Staff Physician with San Francisco Veterans Affairs Health Care System.
Marc Chamberlain, MD No disclosure on file
Javier Ochoa-Reparaz, PhD No disclosure on file
Rhoda Au, PhD Dr. Au has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Dr. Au has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Au has received publishing royalties from a publication relating to health care. Dr. Au has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Davos Alzheimer's Collaborative. Dr. Au has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with High Lantern.
Jesus E. Pina-Garza, MD Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk. Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Pina-Garza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Analysis Group/Acadia. Dr. Pina-Garza has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Same as consultant disclosure. Dr. Pina-Garza has received publishing royalties from a publication relating to health care.
David F. Moore, MD, PhD, FAAN Dr. Moore has nothing to disclose.
Allan I. Levey, MD, PhD Dr. Levey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genuv. Dr. Levey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cognito Therapeutics. Dr. Levey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Levey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karuna Pharmaceuticals. Dr. Levey has received stock or an ownership interest from NextSense. The institution of Dr. Levey has received research support from NIH. The institution of Dr. Levey has received research support from Biogen. The institution of Dr. Levey has received research support from Esai. The institution of Dr. Levey has received research support from AAN. The institution of Dr. Levey has received research support from State of Georgia. The institution of Dr. Levey has received research support from Novartis. The institution of Dr. Levey has received research support from Genentech. Dr. Levey has received intellectual property interests from a discovery or technology relating to health care. Dr. Levey has received personal compensation in the range of $500-$4,999 for serving as a NAPA Avisory Committee Co-Chair with US Dept of Health and Human Services.
Shahram Izadyar, MD, FAAN The institution of Dr. Izadyar has received research support from Xenon Pharmaceuticals. An immediate family member of Dr. Izadyar has received publishing royalties from a publication relating to health care.
Jay Han, MD No disclosure on file
JeeHyun Kwon, MD No disclosure on file
Anne Y. Chan, MD No disclosure on file
Caroline Agha, MD No disclosure on file
Maria Sheila G. Rocha, MD, PhD, FAAN Dr. Rocha has nothing to disclose.
Yannie O. Soo, MD No disclosure on file
Alexander Y. Lau, MD Dr. Lau has nothing to disclose.
Naomi Salins, MBBS No disclosure on file
Clement M. El Khoury, MD No disclosure on file
Evgeny Sidorov, MD Dr. Sidorov has nothing to disclose.
Caroline M. Tanner, MD, PhD, FAAN Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Luis F. Maia No disclosure on file
E. Ann Yeh, MD, MA, FRCPC Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Amy R. Borenstein, PhD, FAAN No disclosure on file
Pierre Labauge, MD Dr. Labauge has nothing to disclose.
Jeff M. Bronstein, MD, PhD Dr. Bronstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ultragenyx. The institution of Dr. Bronstein has received research support from NIH. The institution of Dr. Bronstein has received research support from Levine Foundation.
Tanis J. Ferman, PhD Ms. Ferman has nothing to disclose.
Michael Silber, MB, ChB, FAAN Dr. Silber has received publishing royalties from a publication relating to health care. Dr. Silber has received personal compensation in the range of $500-$4,999 for serving as a Topic writer with UpToDate.
Bijal M. Mehta, MD Dr. Mehta has nothing to disclose.
J W. Langston, MD No disclosure on file
Rachel J. Saunders-Pullman, MD The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Bashar Katirji, MD, FAAN Dr. Katirji has nothing to disclose.
Maya Katz, MD Dr. Katz has received research support from NIH.
Vesna V. Brinar, MD, PhD No disclosure on file
Giovanni Castelnovo No disclosure on file
Sameea Husain Wilson, DO Dr. Husain Wilson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal.
Jennie Davis, DO No disclosure on file
Dong Young Lee, MD, PhD No disclosure on file
Ana M. Silva, MD No disclosure on file
Laura Negrotto Laura Negrotto has received personal compensation for serving as an employee of Merck. Laura Negrotto has received personal compensation in the range of $0-$499 for serving as a Consultant for Entelai.
Conrad Liang, MD Dr. Liang has nothing to disclose.
Kiel Telesford No disclosure on file
Julia Koehn, MD No disclosure on file
Raghu Loganathan, MD No disclosure on file
Vikram Prabhu Vikram Prabhu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zeiss.
Anna Lunemann, MD No disclosure on file
David Reardon No disclosure on file
Christina M. Ulane, MD, PhD Dr. Ulane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. The institution of Dr. Ulane has received research support from Cabaletta Bio. The institution of Dr. Ulane has received research support from Arcellx. The institution of Dr. Ulane has received research support from Sanofi.
Francisco A. Rodriguez Leal, MD Dr. Rodriguez Leal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Rodriguez Leal has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Rodriguez Leal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Benedict Tan, MD No disclosure on file
Andrew D. Levin, MD Dr. Levin has nothing to disclose.
Jose R. Romero, MD The institution of Dr. Romero has received research support from NIH/NIA.
Pascal Maisonobe Pascal Maisonobe has received personal compensation for serving as an employee of ipsen pharma. Pascal Maisonobe has received personal compensation for serving as an employee of Ipsen.
David H. Wagner, PhD No disclosure on file
David Vaillancourt David Vaillancourt has received personal compensation for serving as an employee of Automated Imaging Diagnostics. David Vaillancourt has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of David Vaillancourt has received research support from NIH. David Vaillancourt has received intellectual property interests from a discovery or technology relating to health care.
Dan Waid No disclosure on file
Liang Lu, MD, FAAN Dr. Lu has nothing to disclose.
Jack van Horssen, PhD No disclosure on file
Jill M. Farmer, DO, MPH Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acadia. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. Dr. Farmer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Live. The institution of Dr. Farmer has received research support from Parkinson's Foundation.
Emma Williams No disclosure on file
Yoshiki Sekijima, MD, PhD Yoshiki Sekijima, "MD, PhD" has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam. Yoshiki Sekijima, "MD, PhD" has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer.
Christopher M. DeGiorgio, MD, FAAN Dr. DeGiorgio has received intellectual property interests from a discovery or technology relating to health care.
Raed Alroughani, MD, FAAN Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Mario O. Melcom, MD No disclosure on file
Shin J. Oh, MD, FAAN No disclosure on file
Marc Debouverie, MD Dr. Debouverie has nothing to disclose.
Richard M. Trosch, MD, FAAN Dr. Trosch has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amneal . Dr. Trosch has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine . Dr. Trosch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Francisco J. Carod-Artal, MD, FAAN Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyers. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Meyers Squip. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merz. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Robert T. Wechsler, MD, PhD, FAAN The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equilibre. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich/Jazz. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Epilepsy Studies Consortium. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to AAN interests or activities.
Paul Larson No disclosure on file
Victor H. Patterson, MD No disclosure on file
Erwin B. Montgomery, Jr., MD No disclosure on file
Michael Hutchinson, MD, PhD No disclosure on file
Philippe Coubes, PhD No disclosure on file
Julieta V. Mazziotti, MD No disclosure on file
Alexandr Klistorner Alexandr Klistorner has nothing to disclose.
Alexandra Fuchs, MD No disclosure on file
Cameron Szakacs, PhD No disclosure on file
Davorka Tomic Davorka Tomic has stock in Meck KGaA.
Pierre Tariot Pierre Tariot has received personal compensation for serving as an employee of Banner Alzheimer's Institute. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WebMD. Pierre Tariot has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arcadia. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioXcel. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eNOVA. Pierre Tariot has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos. Pierre Tariot has received intellectual property interests from a discovery or technology relating to health care.
Michael A. Panzara, MD, MPH Dr. Panzara has received personal compensation for serving as an employee of Neurvati Neurosciences. Dr. Panzara has received personal compensation for serving as an employee of GRIN Therapeutics. Dr. Panzara has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Wave Life Sciences. Dr. Panzara has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Athira Pharma. Dr. Panzara has stock in GRIN Therapeutics. Dr. Panzara has stock in Cadenza Bio. Dr. Panzara has stock in Athira Pharma. Dr. Panzara has stock in Wave Life Sciences. Dr. Panzara has stock in Sanofi.
David K. Li, MD Dr. Li has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Academy of Health Care Learning. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Consortium of MS Centers.
Melanie Brennan No disclosure on file
Janet Johnson No disclosure on file
Lynn M. James Ms. James has received personal compensation for serving as an employee of AbbVie. Ms. James has stock in AbbVie.
Matthew W. Cravets No disclosure on file
Elizabeth Hur, PhD Dr. Hur has received personal compensation for serving as an employee of Averitas Pharma.
Aaron L. Berkowitz, MD, PhD, FAAN Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Berkowitz has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill 好色先生. Dr. Berkowitz has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as a Content creator with Clinical problem Solvers. Dr. Berkowitz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Thieme Publisher.
Susan A. Eaton, PharmD No disclosure on file
Marta San Luciano, MD, FAAN Dr. San Luciano has received research support from NIH (NINDS). Dr. San Luciano has received research support from Raynor Cerebellum Project.
Leslie Leahy, PhD Dr. Leahy has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Vigil Neuroscience. Dr. Leahy has stock in Ovid Therapeutics.
Maher Fakhouri, MD Dr. Fakhouri has nothing to disclose.
Cesar C. Santos, MD No disclosure on file
Michael W. O'Dell, MD Michael O'Dell, 15766 has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Michael O'Dell, 15766 has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Franklin College of Indiana.
Paul Frohna, MD, PhD, PharmD No disclosure on file
Robert A. Dean Robert A. Dean has received personal compensation for serving as an employee of Acumen Pharmaceutics. Robert A. Dean has received personal compensation for serving as an employee of Gates Ventures. Robert A. Dean has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Robert A Dean Consulting, LLC. Robert A. Dean has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
Lars Bauer, MD No disclosure on file
Betsy N. Williams, PhD Dr. Williams has received personal compensation for serving as an employee of IQVIA.
Sylvia Klineova, MD Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Klineova has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Klineova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Mahnaz Asgharnejad, PharmD Mahnaz Asgharnejad, PharmD has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Mahnaz Asgharnejad, PharmD has stock in GlaxoSmithKline. Mahnaz Asgharnejad, PharmD has stock in Takeda Pharmaceuticals.
Inge Meijer, MD, PhD Dr. Meijer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Dr. Meijer has received intellectual property interests from a discovery or technology relating to health care.
Becky J. Parks, MD Dr. Parks has received personal compensation for serving as an employee of Alexion Pharmaceuticals. An immediate family member of Dr. Parks has received personal compensation for serving as an employee of Edward P. Evans Foundation. Dr. Parks has stock in Biogen. An immediate family member of Dr. Parks has stock in Regeneron. Dr. Parks has stock in Blueprint Medicines. Dr. Parks has stock in Sanofi. An immediate family member of Dr. Parks has stock in Vertex. Dr. Parks has stock in AstraZeneca. The institution of an immediate family member of Dr. Parks has received research support from NIH/NCI. The institution of an immediate family member of Dr. Parks has received research support from Leukemia & Lymphoma Society. The institution of an immediate family member of Dr. Parks has received research support from AstraZeneca Scholar Award.
Manoj Raghavan, MD, PhD Dr. Raghavan has nothing to disclose.
Paul M. Katz, MD Dr. Katz has nothing to disclose.
Deborah F. Mason, FRACP Dr. Mason has nothing to disclose.
Linda Leary, MD No disclosure on file
Barry E. Gidal, PhD Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai . Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich. Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK life sciences . Dr. Gidal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK life science .
Ahmed A. Malik, MD No disclosure on file
Nicole Daneault, MD No disclosure on file
John K. Fink, MD No disclosure on file
Patrick M. Kochanek, MD, MCCM Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Washington. Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Johns Hopkins Health System. Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for de Boisblanc Law Firm. The institution of Patrick M. Kochanek, MD, MCCM has received research support from Chuck Noll Foundation. The institution of Patrick M. Kochanek, MD, MCCM has received research support from NIH. Patrick M. Kochanek, MD, MCCM has received publishing royalties from a publication relating to health care.
Angela Y. Peters, MD The institution of Dr. Peters has received research support from NIH.
Vivay Peter Misra, MD No disclosure on file
Dennys Reyes, MD No disclosure on file
Alexis B. Shaefer, MD Dr. Shaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Shaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Takeda. Dr. Shaefer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Takeda. Dr. Shaefer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law firms.
Abraham P. Thomas, MD No disclosure on file
Shufang Wang No disclosure on file
Jafar Kafaie, MD, PhD, FAAN Dr. Kafaie has nothing to disclose.
Steven M. Wolf, MD Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Assertio. Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurilis. Dr. Wolf has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MOnteris . Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus . The institution of Dr. Wolf has received research support from Neuropace. The institution of Dr. Wolf has received research support from Eisai. The institution of Dr. Wolf has received research support from Aguestive. The institution of Dr. Wolf has received research support from Neurilis . The institution of Dr. Wolf has received research support from UCB. The institution of Dr. Wolf has received research support from SKLife . The institution of Dr. Wolf has received research support from Longboard . The institution of Dr. Wolf has received research support from Takeda. The institution of Dr. Wolf has received research support from biohaven. The institution of Dr. Wolf has received research support from Assertio. Dr. Wolf has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolf has received publishing royalties from a publication relating to health care.
Ali Sultan-Qurraie, MD No disclosure on file
Amer Malik, MD Dr. Malik has nothing to disclose.
Oleg Y. Chernyshev, MD, PhD, FAAN Dr. Chernyshev has nothing to disclose.
Bhaskar Roy, MD, FAAN Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has stock in Cabaletta bio. . Dr. Roy has stock in Pfizer. Dr. Roy has stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
Brett R. Graham, MD No disclosure on file
Joanna I. Ramiro, MD No disclosure on file
Deena Nasr, DO Dr. Nasr has nothing to disclose.
Ilana M. Ruff, MD Dr. Ruff has nothing to disclose.
Mark J. Zuckerman, MD No disclosure on file
Collin H. York No disclosure on file
Tomas K. Odergren No disclosure on file
Rebecca A. Harrison, MD No disclosure on file
Amr H. Ewida, MD Dr. Ewida has nothing to disclose.
Augusto A. Miravalle, MD, FAAN Dr. Miravalle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Miravalle has received research support from Genzyme. The institution of Dr. Miravalle has received research support from EMD Serono. The institution of Dr. Miravalle has received research support from Alexion.
Rivka Sachdev, MD No disclosure on file
Yasaman Kianirad, MD Dr. Kianirad has nothing to disclose.
Idanis Berrios Morales, MD Dr. Berrios Morales has nothing to disclose.
Joseph C. McCall, MD No disclosure on file
Jeffrey C. Wagner, MD Dr. Wagner has nothing to disclose.
Adam K. Kney, MD No disclosure on file
Yonglu Huang, MD, PhD No disclosure on file
Nathan H. Sit, MD No disclosure on file
Carlos A. Perez, MD Dr. Perez has received personal compensation for serving as an employee of Sanofi-Genzyme.
Neha Prakash, MD The institution of Dr. Prakash has received research support from UCB Biosciences Inc.. The institution of Dr. Prakash has received research support from Parkinson Foundation.
Varun B. Shah, MD Dr. Shah has nothing to disclose.
Shyamal Mehta, MD, PhD, FAAN Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharma. Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CNS Ratings.
Amy Chan, MD Dr. Chan has nothing to disclose.
Daniel Freedman, DO Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedStudy. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Stoll Keenon Ogden.
Cecilia Vidal, MD No disclosure on file
Anindita Deb, MD, FAAN Dr. Deb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altec.
Ali Razmara, MD, PhD No disclosure on file
Lakshmi Shankar, MD Dr. Shankar has nothing to disclose.
Joel S. Steinberg, MD No disclosure on file
Anita Tipirneni, MD No disclosure on file
Shila Azodi, MD Dr. Azodi has nothing to disclose.
Brynn K. Dredla, MD The institution of Dr. Dredla has received research support from NIH.
Marissa N. Dean, MD The institution of Dr. Dean has received research support from Hoffman-La Roche. The institution of Dr. Dean has received research support from Vaccinex Inc.. The institution of Dr. Dean has received research support from Abbvie, Inc.. The institution of Dr. Dean has received research support from Retrophin, Inc.. The institution of Dr. Dean has received research support from Annexon, Inc.. The institution of Dr. Dean has received research support from Neurocrine Biosciences. The institution of Dr. Dean has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Dean has received research support from CHDI Foundation. The institution of Dr. Dean has received research support from Eli Lily and Company. The institution of Dr. Dean has received research support from United States Army Medical Research and Development Command. The institution of Dr. Dean has received research support from UniQure Biopharma B.V.. The institution of Dr. Dean has received research support from Neuraly, Inc.. The institution of Dr. Dean has received research support from Praxis Precision Medicines.
Alissa A. Chitlangia, MD Dr. Chitlangia has nothing to disclose.
Christopher J. Southwood, MD No disclosure on file
Adam Aubuchon, MD No disclosure on file
Geidy Serrano Geidy Serrano has nothing to disclose.
Matsanga L. Kaseka, MD No disclosure on file
Rajiv Narula, MD No disclosure on file
Daniel T. Lackland, PhD An immediate family member of Prof. Lackland has received personal compensation for serving as an employee of Sound Pharmacetical. Prof. Lackland has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley Publishing. Prof. Lackland has received publishing royalties from a publication relating to health care.
Raja S. Boddepalli, MD No disclosure on file
Laura Wilson, MD No disclosure on file
Ales Tomek, MD No disclosure on file
Keren Regev, MD Dr. Regev has nothing to disclose.
Nitin Goyal, MD No disclosure on file
Sirin Gandhi, MBBS Dr. Gandhi has nothing to disclose.
Natalie Gillson, MD No disclosure on file
Amelia K. Adcock, MD The institution of an immediate family member of Dr. Adcock has received research support from NIH.
Kateryna Kurako, MD Dr. Kurako has nothing to disclose.
Fnu Abhi Pandhi, MD No disclosure on file
Haseeb A. Rahman, MD Dr. Rahman has nothing to disclose.
Serge Khelemsky, DO No disclosure on file
DonRaphael P. Wynn, MD Dr. Wynn has nothing to disclose.
Ihtesham Qureshi, MD No disclosure on file
Joana C. Dias, MD No disclosure on file
Henrique D. Rodrigues Cal, MD Dr. Rodrigues Cal has nothing to disclose.
Tiana E. Cruz No disclosure on file
Rachelle Dugue, MD, PhD Dr. Dugue has nothing to disclose.
Asaff Harel, MD Dr. Harel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute.
Andrew Ferree, MD, PhD Dr. Ferree has nothing to disclose.
Jessica Chorostecki-Vigrass No disclosure on file
Omar S. Shah, MD No disclosure on file
Bernd C. Kieseier, MD Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.
Salman Farooq, MD No disclosure on file
Meredith A. Bryarly, MD The institution of Dr. Bryarly has received research support from Theravance.
Steven Factor, MD No disclosure on file
Mohamed Salah No disclosure on file
Savary Om No disclosure on file
Milena Rodriguez Alvarez, MD No disclosure on file
Xiaoping Ning Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical . Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical.
Leonardo Almeida No disclosure on file
Megan Quimby Ms. Quimby has nothing to disclose.
Razina Aziz-Bose, MD Dr. Aziz-Bose has nothing to disclose.
Michael E. Theriault, MD No disclosure on file
Emily Thorn No disclosure on file